{
    "medicine_id": "82b90850ba6b3bc09e0fa52acb5e157881cc82d5",
    "platform_id": "DB00424",
    "metadata": {
        "name": "Anaspaz 0 125 mg 1 Tablet orally disintegrating",
        "composition": "0 125 mg 1 Hyoscyamine",
        "clinical_particulars": {
            "therapeutic_indications": "For treatment of bladder spasms peptic ulcer disease diverticulitis colic irritable bowel syndrome cystitis and pancreatitis Also used to treat certain heart conditions to control the symptoms of Parkinson s disease and rhinitis",
            "contraindications": {
                "disease": "Symptoms of overdose include headache nausea vomiting blurred vision dilated pupils hot dry skin dizziness dryness of the mouth difficulty in swallowing and CNS stimulation LD sub 50 sub mg kg orally in rat",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "L Hyoscyamine the active optical isomer of atropine dl hyoscyamine is a tertiary amine anticholinergic gastrointestinal agent",
                "excipients": "NA",
                "incompatibilities": [
                    {
                        "drugbank-id": "DB08897",
                        "description": "The risk or severity of adverse effects can be increased when Hyoscyamine is combined with Aclidinium"
                    },
                    {
                        "drugbank-id": "DB06148",
                        "description": "Mianserin may increase the anticholinergic activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB08893",
                        "description": "The risk or severity of urinary retention can be increased when Hyoscyamine is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB00761",
                        "description": "The risk or severity of gastrointestinal ulceration can be increased when Hyoscyamine is combined with Potassium chloride"
                    },
                    {
                        "drugbank-id": "DB01278",
                        "description": "The risk or severity of reduced gastrointestinal motility can be increased when Pramlintide is combined with Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB09527",
                        "description": "The therapeutic efficacy of Secretin porcine can be decreased when used in combination with Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB01409",
                        "description": "The risk or severity of adverse effects can be increased when Hyoscyamine is combined with Tiotropium"
                    },
                    {
                        "drugbank-id": "DB00273",
                        "description": "The risk or severity of hyperthermia and oligohydrosis can be increased when Hyoscyamine is combined with Topiramate"
                    },
                    {
                        "drugbank-id": "DB09076",
                        "description": "The risk or severity of adverse effects can be increased when Hyoscyamine is combined with Umeclidinium"
                    },
                    {
                        "drugbank-id": "DB00986",
                        "description": "The risk or severity of adverse effects can be increased when Hyoscyamine is combined with Glycopyrronium"
                    },
                    {
                        "drugbank-id": "DB01377",
                        "description": "Magnesium oxide can cause a decrease in the absorption of Hyoscyamine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB01390",
                        "description": "Sodium bicarbonate can cause a decrease in the absorption of Hyoscyamine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB06723",
                        "description": "Aluminum hydroxide can cause a decrease in the absorption of Hyoscyamine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB06724",
                        "description": "Calcium carbonate can cause a decrease in the absorption of Hyoscyamine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB08938",
                        "description": "Magaldrate can cause a decrease in the absorption of Hyoscyamine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB09104",
                        "description": "Magnesium hydroxide can cause a decrease in the absorption of Hyoscyamine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB09281",
                        "description": "Magnesium trisilicate can cause a decrease in the absorption of Hyoscyamine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB09481",
                        "description": "Magnesium carbonate can cause a decrease in the absorption of Hyoscyamine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB13209",
                        "description": "Bismuth subnitrate can cause a decrease in the absorption of Hyoscyamine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB13249",
                        "description": "Magnesium silicate can cause a decrease in the absorption of Hyoscyamine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB13280",
                        "description": "Aluminium acetoacetate can cause a decrease in the absorption of Hyoscyamine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB13322",
                        "description": "Hydrotalcite can cause a decrease in the absorption of Hyoscyamine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB13486",
                        "description": "Magnesium peroxide can cause a decrease in the absorption of Hyoscyamine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB13595",
                        "description": "Almasilate can cause a decrease in the absorption of Hyoscyamine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB13626",
                        "description": "Aluminium glycinate can cause a decrease in the absorption of Hyoscyamine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB13650",
                        "description": "Aloglutamol can cause a decrease in the absorption of Hyoscyamine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB13829",
                        "description": "Calcium silicate can cause a decrease in the absorption of Hyoscyamine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB14517",
                        "description": "Aluminium phosphate can cause a decrease in the absorption of Hyoscyamine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00083",
                        "description": "The risk or severity of adverse effects can be increased when Hyoscyamine is combined with Botulinum toxin type A"
                    },
                    {
                        "drugbank-id": "DB00040",
                        "description": "Hyoscyamine may increase the gastrointestinal motility reducing activities of Glucagon"
                    },
                    {
                        "drugbank-id": "DB00391",
                        "description": "Hyoscyamine may increase the anticholinergic activities of Sulpiride"
                    },
                    {
                        "drugbank-id": "DB00042",
                        "description": "The risk or severity of adverse effects can be increased when Hyoscyamine is combined with Botulinum Toxin Type B"
                    },
                    {
                        "drugbank-id": "DB09272",
                        "description": "The risk or severity of constipation can be increased when Hyoscyamine is combined with Eluxadoline"
                    },
                    {
                        "drugbank-id": "DB09290",
                        "description": "The risk or severity of constipation can be increased when Hyoscyamine is combined with Ramosetron"
                    },
                    {
                        "drugbank-id": "DB00704",
                        "description": "The risk or severity of adverse effects can be increased when Hyoscyamine is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB01459",
                        "description": "The risk or severity of adverse effects can be increased when Hyoscyamine is combined with Bezitramide"
                    },
                    {
                        "drugbank-id": "DB00193",
                        "description": "The risk or severity of adverse effects can be increased when Tramadol is combined with Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00295",
                        "description": "The risk or severity of adverse effects can be increased when Morphine is combined with Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00318",
                        "description": "The risk or severity of adverse effects can be increased when Codeine is combined with Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00327",
                        "description": "The risk or severity of adverse effects can be increased when Hydromorphone is combined with Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00454",
                        "description": "The risk or severity of adverse effects can be increased when Meperidine is combined with Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00497",
                        "description": "The risk or severity of adverse effects can be increased when Oxycodone is combined with Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00611",
                        "description": "The risk or severity of adverse effects can be increased when Butorphanol is combined with Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00647",
                        "description": "The risk or severity of adverse effects can be increased when Dextropropoxyphene is combined with Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00652",
                        "description": "The risk or severity of adverse effects can be increased when Pentazocine is combined with Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00708",
                        "description": "The risk or severity of adverse effects can be increased when Sufentanil is combined with Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00802",
                        "description": "The risk or severity of adverse effects can be increased when Alfentanil is combined with Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00813",
                        "description": "The risk or severity of adverse effects can be increased when Fentanyl is combined with Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00844",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00854",
                        "description": "The risk or severity of adverse effects can be increased when Levorphanol is combined with Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00899",
                        "description": "The risk or severity of adverse effects can be increased when Remifentanil is combined with Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00921",
                        "description": "The risk or severity of adverse effects can be increased when Buprenorphine is combined with Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00956",
                        "description": "The risk or severity of adverse effects can be increased when Hydrocodone is combined with Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB01081",
                        "description": "The risk or severity of adverse effects can be increased when Diphenoxylate is combined with Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB01192",
                        "description": "The risk or severity of adverse effects can be increased when Oxymorphone is combined with Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB01209",
                        "description": "The risk or severity of adverse effects can be increased when Dezocine is combined with Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB01433",
                        "description": "The risk or severity of adverse effects can be increased when Methadyl acetate is combined with Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB01450",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroetorphine is combined with Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB01452",
                        "description": "The risk or severity of adverse effects can be increased when Diamorphine is combined with Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB01466",
                        "description": "The risk or severity of adverse effects can be increased when Ethylmorphine is combined with Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB01497",
                        "description": "The risk or severity of adverse effects can be increased when Etorphine is combined with Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB01529",
                        "description": "The risk or severity of adverse effects can be increased when Dextromoramide is combined with Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB01531",
                        "description": "The risk or severity of adverse effects can be increased when Desomorphine is combined with Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB01535",
                        "description": "The risk or severity of adverse effects can be increased when Carfentanil is combined with Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB01551",
                        "description": "The risk or severity of adverse effects can be increased when Dihydrocodeine is combined with Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB01555",
                        "description": "The risk or severity of adverse effects can be increased when Alphacetylmethadol is combined with Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB01565",
                        "description": "The risk or severity of adverse effects can be increased when Dihydromorphine is combined with Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB06204",
                        "description": "The risk or severity of adverse effects can be increased when Tapentadol is combined with Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB06738",
                        "description": "The risk or severity of adverse effects can be increased when Ketobemidone is combined with Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB08861",
                        "description": "The risk or severity of adverse effects can be increased when DPDPE is combined with Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB09174",
                        "description": "The risk or severity of adverse effects can be increased when Lofentanil is combined with Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB11609",
                        "description": "The risk or severity of adverse effects can be increased when Normethadone is combined with Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB12492",
                        "description": "The risk or severity of adverse effects can be increased when Piritramide is combined with Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB13160",
                        "description": "The risk or severity of adverse effects can be increased when Alphaprodine is combined with Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB13454",
                        "description": "The risk or severity of adverse effects can be increased when Nicomorphine is combined with Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB13478",
                        "description": "The risk or severity of adverse effects can be increased when Meptazinol is combined with Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB13605",
                        "description": "The risk or severity of adverse effects can be increased when Phenoperidine is combined with Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB13606",
                        "description": "The risk or severity of adverse effects can be increased when Phenazocine is combined with Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB13787",
                        "description": "The risk or severity of adverse effects can be increased when Tilidine is combined with Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB15360",
                        "description": "The risk or severity of adverse effects can be increased when Carfentanil C 11 is combined with Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00333",
                        "description": "The risk or severity of adverse effects can be increased when Hyoscyamine is combined with Methadone"
                    },
                    {
                        "drugbank-id": "DB01227",
                        "description": "The risk or severity of adverse effects can be increased when Hyoscyamine is combined with Levacetylmethadol"
                    },
                    {
                        "drugbank-id": "DB15465",
                        "description": "The risk or severity of adverse effects can be increased when Hyoscyamine is combined with Benzhydrocodone"
                    },
                    {
                        "drugbank-id": "DB00209",
                        "description": "The risk or severity of adverse effects can be increased when Trospium is combined with Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00219",
                        "description": "The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00340",
                        "description": "The risk or severity of adverse effects can be increased when Metixene is combined with Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00376",
                        "description": "The risk or severity of adverse effects can be increased when Trihexyphenidyl is combined with Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00383",
                        "description": "The risk or severity of adverse effects can be increased when Oxyphencyclimine is combined with Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00387",
                        "description": "The risk or severity of adverse effects can be increased when Procyclidine is combined with Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00462",
                        "description": "The risk or severity of adverse effects can be increased when Hyoscyamine is combined with Methscopolamine bromide"
                    },
                    {
                        "drugbank-id": "DB00496",
                        "description": "The risk or severity of adverse effects can be increased when Hyoscyamine is combined with Darifenacin"
                    },
                    {
                        "drugbank-id": "DB00505",
                        "description": "The risk or severity of adverse effects can be increased when Hyoscyamine is combined with Tridihexethyl"
                    },
                    {
                        "drugbank-id": "DB00517",
                        "description": "The risk or severity of adverse effects can be increased when Hyoscyamine is combined with Anisotropine methylbromide"
                    },
                    {
                        "drugbank-id": "DB00657",
                        "description": "The risk or severity of adverse effects can be increased when Hyoscyamine is combined with Mecamylamine"
                    },
                    {
                        "drugbank-id": "DB00670",
                        "description": "The risk or severity of adverse effects can be increased when Hyoscyamine is combined with Pirenzepine"
                    },
                    {
                        "drugbank-id": "DB00725",
                        "description": "The risk or severity of adverse effects can be increased when Hyoscyamine is combined with Homatropine methylbromide"
                    },
                    {
                        "drugbank-id": "DB00767",
                        "description": "The risk or severity of adverse effects can be increased when Hyoscyamine is combined with Benzquinamide"
                    },
                    {
                        "drugbank-id": "DB00782",
                        "description": "The risk or severity of adverse effects can be increased when Hyoscyamine is combined with Propantheline"
                    },
                    {
                        "drugbank-id": "DB00804",
                        "description": "The risk or severity of adverse effects can be increased when Hyoscyamine is combined with Dicyclomine"
                    },
                    {
                        "drugbank-id": "DB00809",
                        "description": "The risk or severity of adverse effects can be increased when Hyoscyamine is combined with Tropicamide"
                    },
                    {
                        "drugbank-id": "DB00940",
                        "description": "The risk or severity of adverse effects can be increased when Hyoscyamine is combined with Methantheline"
                    },
                    {
                        "drugbank-id": "DB00942",
                        "description": "The risk or severity of adverse effects can be increased when Hyoscyamine is combined with Cycrimine"
                    },
                    {
                        "drugbank-id": "DB00979",
                        "description": "The risk or severity of adverse effects can be increased when Hyoscyamine is combined with Cyclopentolate"
                    },
                    {
                        "drugbank-id": "DB01062",
                        "description": "The risk or severity of adverse effects can be increased when Hyoscyamine is combined with Oxybutynin"
                    },
                    {
                        "drugbank-id": "DB01090",
                        "description": "The risk or severity of adverse effects can be increased when Hyoscyamine is combined with Pentolinium"
                    },
                    {
                        "drugbank-id": "DB01116",
                        "description": "The risk or severity of adverse effects can be increased when Hyoscyamine is combined with Trimethaphan"
                    },
                    {
                        "drugbank-id": "DB01148",
                        "description": "The risk or severity of adverse effects can be increased when Hyoscyamine is combined with Flavoxate"
                    },
                    {
                        "drugbank-id": "DB01161",
                        "description": "The risk or severity of adverse effects can be increased when Hyoscyamine is combined with Chloroprocaine"
                    },
                    {
                        "drugbank-id": "DB01231",
                        "description": "The risk or severity of adverse effects can be increased when Hyoscyamine is combined with Diphenidol"
                    },
                    {
                        "drugbank-id": "DB01288",
                        "description": "The risk or severity of adverse effects can be increased when Hyoscyamine is combined with Fenoterol"
                    },
                    {
                        "drugbank-id": "DB01496",
                        "description": "The risk or severity of adverse effects can be increased when Hyoscyamine is combined with Dihydro 2 thioxo 5 5 2 trifluoromethyl phenyl 2 furanyl methyl 4 6 1H 5H pyrimidinedione"
                    },
                    {
                        "drugbank-id": "DB01625",
                        "description": "The risk or severity of adverse effects can be increased when Hyoscyamine is combined with Isopropamide"
                    },
                    {
                        "drugbank-id": "DB04843",
                        "description": "The risk or severity of adverse effects can be increased when Hyoscyamine is combined with Mepenzolate"
                    },
                    {
                        "drugbank-id": "DB06702",
                        "description": "The risk or severity of adverse effects can be increased when Hyoscyamine is combined with Fesoterodine"
                    },
                    {
                        "drugbank-id": "DB06787",
                        "description": "The risk or severity of adverse effects can be increased when Hyoscyamine is combined with Hexocyclium"
                    },
                    {
                        "drugbank-id": "DB08801",
                        "description": "The risk or severity of adverse effects can be increased when Hyoscyamine is combined with Dimetindene"
                    },
                    {
                        "drugbank-id": "DB08997",
                        "description": "The risk or severity of adverse effects can be increased when Hyoscyamine is combined with Dexetimide"
                    },
                    {
                        "drugbank-id": "DB09007",
                        "description": "The risk or severity of adverse effects can be increased when Hyoscyamine is combined with Chlorphenoxamine"
                    },
                    {
                        "drugbank-id": "DB09262",
                        "description": "The risk or severity of adverse effects can be increased when Hyoscyamine is combined with Imidafenacin"
                    },
                    {
                        "drugbank-id": "DB09300",
                        "description": "The risk or severity of adverse effects can be increased when Hyoscyamine is combined with Butylscopolamine"
                    },
                    {
                        "drugbank-id": "DB11181",
                        "description": "The risk or severity of adverse effects can be increased when Hyoscyamine is combined with Homatropine"
                    },
                    {
                        "drugbank-id": "DB11235",
                        "description": "The risk or severity of adverse effects can be increased when Hyoscyamine is combined with Thonzylamine"
                    },
                    {
                        "drugbank-id": "DB11315",
                        "description": "The risk or severity of adverse effects can be increased when Hyoscyamine is combined with Methscopolamine"
                    },
                    {
                        "drugbank-id": "DB11855",
                        "description": "The risk or severity of adverse effects can be increased when Hyoscyamine is combined with Revefenacin"
                    },
                    {
                        "drugbank-id": "DB12086",
                        "description": "The risk or severity of adverse effects can be increased when Hyoscyamine is combined with Oxitropium"
                    },
                    {
                        "drugbank-id": "DB12278",
                        "description": "The risk or severity of adverse effects can be increased when Hyoscyamine is combined with Propiverine"
                    },
                    {
                        "drugbank-id": "DB12526",
                        "description": "The risk or severity of adverse effects can be increased when Hyoscyamine is combined with Batefenterol"
                    },
                    {
                        "drugbank-id": "DB12554",
                        "description": "The risk or severity of adverse effects can be increased when Hyoscyamine is combined with Mebeverine"
                    },
                    {
                        "drugbank-id": "DB13252",
                        "description": "The risk or severity of adverse effects can be increased when Hyoscyamine is combined with Tropatepine"
                    },
                    {
                        "drugbank-id": "DB13254",
                        "description": "The risk or severity of adverse effects can be increased when Hyoscyamine is combined with Prifinium"
                    },
                    {
                        "drugbank-id": "DB13351",
                        "description": "The risk or severity of adverse effects can be increased when Hyoscyamine is combined with Piperidolate"
                    },
                    {
                        "drugbank-id": "DB13369",
                        "description": "The risk or severity of adverse effects can be increased when Hyoscyamine is combined with Benzilone"
                    },
                    {
                        "drugbank-id": "DB13380",
                        "description": "The risk or severity of adverse effects can be increased when Hyoscyamine is combined with Difemerine"
                    },
                    {
                        "drugbank-id": "DB13413",
                        "description": "The risk or severity of adverse effects can be increased when Hyoscyamine is combined with Phenglutarimide"
                    },
                    {
                        "drugbank-id": "DB13448",
                        "description": "The risk or severity of adverse effects can be increased when Hyoscyamine is combined with Mazaticol"
                    },
                    {
                        "drugbank-id": "DB13468",
                        "description": "The risk or severity of adverse effects can be increased when Hyoscyamine is combined with Etybenzatropine"
                    },
                    {
                        "drugbank-id": "DB13507",
                        "description": "The risk or severity of adverse effects can be increased when Hyoscyamine is combined with Poldine"
                    },
                    {
                        "drugbank-id": "DB13542",
                        "description": "The risk or severity of adverse effects can be increased when Hyoscyamine is combined with Bevonium"
                    },
                    {
                        "drugbank-id": "DB13581",
                        "description": "The risk or severity of adverse effects can be increased when Hyoscyamine is combined with Rociverine"
                    },
                    {
                        "drugbank-id": "DB13619",
                        "description": "The risk or severity of adverse effects can be increased when Hyoscyamine is combined with Bornaprine"
                    },
                    {
                        "drugbank-id": "DB13636",
                        "description": "The risk or severity of adverse effects can be increased when Hyoscyamine is combined with Etanautine"
                    },
                    {
                        "drugbank-id": "DB13666",
                        "description": "The risk or severity of adverse effects can be increased when Hyoscyamine is combined with Tiemonium iodide"
                    },
                    {
                        "drugbank-id": "DB13678",
                        "description": "The risk or severity of adverse effects can be increased when Hyoscyamine is combined with Dihexyverine"
                    },
                    {
                        "drugbank-id": "DB13695",
                        "description": "The risk or severity of adverse effects can be increased when Hyoscyamine is combined with Penthienate"
                    },
                    {
                        "drugbank-id": "DB13720",
                        "description": "The risk or severity of adverse effects can be increased when Hyoscyamine is combined with Diphemanil"
                    },
                    {
                        "drugbank-id": "DB13738",
                        "description": "The risk or severity of adverse effects can be increased when Hyoscyamine is combined with Camylofin"
                    },
                    {
                        "drugbank-id": "DB13759",
                        "description": "The risk or severity of adverse effects can be increased when Hyoscyamine is combined with Fenpiverinium"
                    },
                    {
                        "drugbank-id": "DB13769",
                        "description": "The risk or severity of adverse effects can be increased when Hyoscyamine is combined with Emetonium iodide"
                    },
                    {
                        "drugbank-id": "DB13844",
                        "description": "The risk or severity of adverse effects can be increased when Hyoscyamine is combined with Pipenzolate"
                    },
                    {
                        "drugbank-id": "DB13850",
                        "description": "The risk or severity of adverse effects can be increased when Hyoscyamine is combined with Timepidium"
                    },
                    {
                        "drugbank-id": "DB09271",
                        "description": "The risk or severity of adverse effects can be increased when Hyoscyamine is combined with Cimetropium"
                    },
                    {
                        "drugbank-id": "DB00232",
                        "description": "The serum concentration of Methyclothiazide can be increased when it is combined with Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00310",
                        "description": "The serum concentration of Chlorthalidone can be increased when it is combined with Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00436",
                        "description": "The serum concentration of Bendroflumethiazide can be increased when it is combined with Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00524",
                        "description": "The serum concentration of Metolazone can be increased when it is combined with Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00562",
                        "description": "The serum concentration of Benzthiazide can be increased when it is combined with Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00774",
                        "description": "The serum concentration of Hydroflumethiazide can be increased when it is combined with Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00880",
                        "description": "The serum concentration of Chlorothiazide can be increased when it is combined with Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB01021",
                        "description": "The serum concentration of Trichlormethiazide can be increased when it is combined with Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB01324",
                        "description": "The serum concentration of Polythiazide can be increased when it is combined with Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB01325",
                        "description": "The serum concentration of Quinethazone can be increased when it is combined with Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB13532",
                        "description": "The serum concentration of Cyclopenthiazide can be increased when it is combined with Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB13989",
                        "description": "The serum concentration of Epitizide can be increased when it is combined with Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00622",
                        "description": "Hyoscyamine may increase the arrhythmogenic activities of Nicardipine"
                    },
                    {
                        "drugbank-id": "DB09089",
                        "description": "Hyoscyamine may increase the arrhythmogenic activities of Trimebutine"
                    },
                    {
                        "drugbank-id": "DB00222",
                        "description": "Glimepiride may increase the arrhythmogenic activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00264",
                        "description": "Metoprolol may increase the arrhythmogenic activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00281",
                        "description": "Lidocaine may increase the arrhythmogenic activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00335",
                        "description": "Atenolol may increase the arrhythmogenic activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00379",
                        "description": "Mexiletine may increase the arrhythmogenic activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00401",
                        "description": "Nisoldipine may increase the arrhythmogenic activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00511",
                        "description": "Hyoscyamine may increase the arrhythmogenic activities of Acetyldigitoxin"
                    },
                    {
                        "drugbank-id": "DB00521",
                        "description": "Hyoscyamine may increase the arrhythmogenic activities of Carteolol"
                    },
                    {
                        "drugbank-id": "DB00528",
                        "description": "Hyoscyamine may increase the arrhythmogenic activities of Lercanidipine"
                    },
                    {
                        "drugbank-id": "DB00825",
                        "description": "Hyoscyamine may increase the arrhythmogenic activities of Levomenthol"
                    },
                    {
                        "drugbank-id": "DB01056",
                        "description": "Hyoscyamine may increase the arrhythmogenic activities of Tocainide"
                    },
                    {
                        "drugbank-id": "DB01078",
                        "description": "Hyoscyamine may increase the arrhythmogenic activities of Deslanoside"
                    },
                    {
                        "drugbank-id": "DB01136",
                        "description": "Hyoscyamine may increase the arrhythmogenic activities of Carvedilol"
                    },
                    {
                        "drugbank-id": "DB01203",
                        "description": "Hyoscyamine may increase the arrhythmogenic activities of Nadolol"
                    },
                    {
                        "drugbank-id": "DB01214",
                        "description": "Hyoscyamine may increase the arrhythmogenic activities of Metipranolol"
                    },
                    {
                        "drugbank-id": "DB01297",
                        "description": "Hyoscyamine may increase the arrhythmogenic activities of Practolol"
                    },
                    {
                        "drugbank-id": "DB01429",
                        "description": "Hyoscyamine may increase the arrhythmogenic activities of Aprindine"
                    },
                    {
                        "drugbank-id": "DB03322",
                        "description": "Hyoscyamine may increase the arrhythmogenic activities of Dexpropranolol"
                    },
                    {
                        "drugbank-id": "DB04743",
                        "description": "Hyoscyamine may increase the arrhythmogenic activities of Nimesulide"
                    },
                    {
                        "drugbank-id": "DB04838",
                        "description": "Hyoscyamine may increase the arrhythmogenic activities of Cyclandelate"
                    },
                    {
                        "drugbank-id": "DB04861",
                        "description": "Hyoscyamine may increase the arrhythmogenic activities of Nebivolol"
                    },
                    {
                        "drugbank-id": "DB04920",
                        "description": "Hyoscyamine may increase the arrhythmogenic activities of Clevidipine"
                    },
                    {
                        "drugbank-id": "DB05885",
                        "description": "Hyoscyamine may increase the arrhythmogenic activities of Seletracetam"
                    },
                    {
                        "drugbank-id": "DB06727",
                        "description": "Hyoscyamine may increase the arrhythmogenic activities of Sparteine"
                    },
                    {
                        "drugbank-id": "DB07615",
                        "description": "Hyoscyamine may increase the arrhythmogenic activities of Tranilast"
                    },
                    {
                        "drugbank-id": "DB08162",
                        "description": "Hyoscyamine may increase the arrhythmogenic activities of Fasudil"
                    },
                    {
                        "drugbank-id": "DB08838",
                        "description": "Hyoscyamine may increase the arrhythmogenic activities of Agmatine"
                    },
                    {
                        "drugbank-id": "DB09216",
                        "description": "Hyoscyamine may increase the arrhythmogenic activities of Tolfenamic acid"
                    },
                    {
                        "drugbank-id": "DB09220",
                        "description": "Hyoscyamine may increase the arrhythmogenic activities of Nicorandil"
                    },
                    {
                        "drugbank-id": "DB09227",
                        "description": "Hyoscyamine may increase the arrhythmogenic activities of Barnidipine"
                    },
                    {
                        "drugbank-id": "DB09230",
                        "description": "Hyoscyamine may increase the arrhythmogenic activities of Azelnidipine"
                    },
                    {
                        "drugbank-id": "DB09232",
                        "description": "Hyoscyamine may increase the arrhythmogenic activities of Cilnidipine"
                    },
                    {
                        "drugbank-id": "DB09234",
                        "description": "Hyoscyamine may increase the arrhythmogenic activities of Darodipine"
                    },
                    {
                        "drugbank-id": "DB09238",
                        "description": "Hyoscyamine may increase the arrhythmogenic activities of Manidipine"
                    },
                    {
                        "drugbank-id": "DB09240",
                        "description": "Hyoscyamine may increase the arrhythmogenic activities of Niludipine"
                    },
                    {
                        "drugbank-id": "DB11960",
                        "description": "Hyoscyamine may increase the arrhythmogenic activities of Carboxyamidotriazole"
                    },
                    {
                        "drugbank-id": "DB12092",
                        "description": "Hyoscyamine may increase the arrhythmogenic activities of Naftopidil"
                    },
                    {
                        "drugbank-id": "DB12212",
                        "description": "Hyoscyamine may increase the arrhythmogenic activities of Landiolol"
                    },
                    {
                        "drugbank-id": "DB12704",
                        "description": "Hyoscyamine may increase the arrhythmogenic activities of Spiradoline"
                    },
                    {
                        "drugbank-id": "DB13240",
                        "description": "Hyoscyamine may increase the arrhythmogenic activities of Cymarin"
                    },
                    {
                        "drugbank-id": "DB13401",
                        "description": "Hyoscyamine may increase the arrhythmogenic activities of Metildigoxin"
                    },
                    {
                        "drugbank-id": "DB13635",
                        "description": "Hyoscyamine may increase the arrhythmogenic activities of Tiracizine"
                    },
                    {
                        "drugbank-id": "DB13645",
                        "description": "Hyoscyamine may increase the arrhythmogenic activities of Ethacizine"
                    },
                    {
                        "drugbank-id": "DB13718",
                        "description": "Hyoscyamine may increase the arrhythmogenic activities of Hydroquinine"
                    },
                    {
                        "drugbank-id": "DB13746",
                        "description": "Hyoscyamine may increase the arrhythmogenic activities of Bioallethrin"
                    },
                    {
                        "drugbank-id": "DB13775",
                        "description": "Hyoscyamine may increase the arrhythmogenic activities of Tertatolol"
                    },
                    {
                        "drugbank-id": "DB13835",
                        "description": "Hyoscyamine may increase the arrhythmogenic activities of Caroverine"
                    },
                    {
                        "drugbank-id": "DB13863",
                        "description": "Hyoscyamine may increase the arrhythmogenic activities of Fosfructose"
                    },
                    {
                        "drugbank-id": "DB13961",
                        "description": "Hyoscyamine may increase the arrhythmogenic activities of Fish oil"
                    },
                    {
                        "drugbank-id": "DB14064",
                        "description": "Hyoscyamine may increase the arrhythmogenic activities of Emopamil"
                    },
                    {
                        "drugbank-id": "DB14065",
                        "description": "Hyoscyamine may increase the arrhythmogenic activities of Lomerizine"
                    },
                    {
                        "drugbank-id": "DB14066",
                        "description": "Hyoscyamine may increase the arrhythmogenic activities of Tetrandrine"
                    },
                    {
                        "drugbank-id": "DB14068",
                        "description": "Hyoscyamine may increase the arrhythmogenic activities of Dexniguldipine"
                    },
                    {
                        "drugbank-id": "DB14207",
                        "description": "Hyoscyamine may increase the arrhythmogenic activities of Fosinoprilat"
                    },
                    {
                        "drugbank-id": "DB15300",
                        "description": "Hyoscyamine may increase the arrhythmogenic activities of Hydroquinidine"
                    },
                    {
                        "drugbank-id": "DB15366",
                        "description": "Hyoscyamine may increase the arrhythmogenic activities of SOR C13"
                    },
                    {
                        "drugbank-id": "DB13950",
                        "description": "Hyoscyamine may increase the arrhythmogenic activities of WIN 55212 2"
                    },
                    {
                        "drugbank-id": "DB00230",
                        "description": "Pregabalin may increase the arrhythmogenic activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00347",
                        "description": "Trimethadione may increase the arrhythmogenic activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00555",
                        "description": "Lamotrigine may increase the arrhythmogenic activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00593",
                        "description": "Ethosuximide may increase the arrhythmogenic activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00680",
                        "description": "Moricizine may increase the arrhythmogenic activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00866",
                        "description": "Alprenolol may increase the arrhythmogenic activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00909",
                        "description": "Zonisamide may increase the arrhythmogenic activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB04841",
                        "description": "Flunarizine may increase the arrhythmogenic activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB05246",
                        "description": "Methsuximide may increase the arrhythmogenic activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB06283",
                        "description": "Ziconotide may increase the arrhythmogenic activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB06446",
                        "description": "Dotarizine may increase the arrhythmogenic activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB11699",
                        "description": "Tropisetron may increase the arrhythmogenic activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB12093",
                        "description": "Tetrahydropalmatine may increase the arrhythmogenic activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB12131",
                        "description": "Vinpocetine may increase the arrhythmogenic activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00195",
                        "description": "Hyoscyamine may increase the arrhythmogenic activities of Betaxolol"
                    },
                    {
                        "drugbank-id": "DB00343",
                        "description": "Hyoscyamine may increase the arrhythmogenic activities of Diltiazem"
                    },
                    {
                        "drugbank-id": "DB00393",
                        "description": "Hyoscyamine may increase the arrhythmogenic activities of Nimodipine"
                    },
                    {
                        "drugbank-id": "DB00568",
                        "description": "Hyoscyamine may increase the arrhythmogenic activities of Cinnarizine"
                    },
                    {
                        "drugbank-id": "DB00571",
                        "description": "Hyoscyamine may increase the arrhythmogenic activities of Propranolol"
                    },
                    {
                        "drugbank-id": "DB00640",
                        "description": "Hyoscyamine may increase the arrhythmogenic activities of Adenosine"
                    },
                    {
                        "drugbank-id": "DB00836",
                        "description": "Hyoscyamine may increase the arrhythmogenic activities of Loperamide"
                    },
                    {
                        "drugbank-id": "DB00922",
                        "description": "Hyoscyamine may increase the arrhythmogenic activities of Levosimendan"
                    },
                    {
                        "drugbank-id": "DB01115",
                        "description": "Hyoscyamine may increase the arrhythmogenic activities of Nifedipine"
                    },
                    {
                        "drugbank-id": "DB01182",
                        "description": "Hyoscyamine may increase the arrhythmogenic activities of Propafenone"
                    },
                    {
                        "drugbank-id": "DB01193",
                        "description": "Hyoscyamine may increase the arrhythmogenic activities of Acebutolol"
                    },
                    {
                        "drugbank-id": "DB01195",
                        "description": "Hyoscyamine may increase the arrhythmogenic activities of Flecainide"
                    },
                    {
                        "drugbank-id": "DB01388",
                        "description": "Hyoscyamine may increase the arrhythmogenic activities of Mibefradil"
                    },
                    {
                        "drugbank-id": "DB01580",
                        "description": "Hyoscyamine may increase the arrhythmogenic activities of Oxprenolol"
                    },
                    {
                        "drugbank-id": "DB04825",
                        "description": "Hyoscyamine may increase the arrhythmogenic activities of Prenylamine"
                    },
                    {
                        "drugbank-id": "DB04842",
                        "description": "Hyoscyamine may increase the arrhythmogenic activities of Fluspirilene"
                    },
                    {
                        "drugbank-id": "DB04957",
                        "description": "Hyoscyamine may increase the arrhythmogenic activities of Azimilide"
                    },
                    {
                        "drugbank-id": "DB06200",
                        "description": "Hyoscyamine may increase the arrhythmogenic activities of Tedisamil"
                    },
                    {
                        "drugbank-id": "DB06712",
                        "description": "Hyoscyamine may increase the arrhythmogenic activities of Nilvadipine"
                    },
                    {
                        "drugbank-id": "DB08952",
                        "description": "Hyoscyamine may increase the arrhythmogenic activities of Indenolol"
                    },
                    {
                        "drugbank-id": "DB08980",
                        "description": "Hyoscyamine may increase the arrhythmogenic activities of Fendiline"
                    },
                    {
                        "drugbank-id": "DB08992",
                        "description": "Hyoscyamine may increase the arrhythmogenic activities of Eperisone"
                    },
                    {
                        "drugbank-id": "DB09224",
                        "description": "Hyoscyamine may increase the arrhythmogenic activities of Melperone"
                    },
                    {
                        "drugbank-id": "DB09231",
                        "description": "Hyoscyamine may increase the arrhythmogenic activities of Benidipine"
                    },
                    {
                        "drugbank-id": "DB12286",
                        "description": "Hyoscyamine may increase the arrhythmogenic activities of Simendan"
                    },
                    {
                        "drugbank-id": "DB13500",
                        "description": "Hyoscyamine may increase the arrhythmogenic activities of Otilonium"
                    },
                    {
                        "drugbank-id": "DB13546",
                        "description": "Hyoscyamine may increase the arrhythmogenic activities of Nizofenone"
                    },
                    {
                        "drugbank-id": "DB13652",
                        "description": "Hyoscyamine may increase the arrhythmogenic activities of Bunaftine"
                    },
                    {
                        "drugbank-id": "DB13653",
                        "description": "Hyoscyamine may increase the arrhythmogenic activities of Lorcainide"
                    },
                    {
                        "drugbank-id": "DB13791",
                        "description": "Hyoscyamine may increase the arrhythmogenic activities of Penfluridol"
                    },
                    {
                        "drugbank-id": "DB14063",
                        "description": "Hyoscyamine may increase the arrhythmogenic activities of Dexverapamil"
                    },
                    {
                        "drugbank-id": "DB00204",
                        "description": "Hyoscyamine may increase the arrhythmogenic activities of Dofetilide"
                    },
                    {
                        "drugbank-id": "DB00280",
                        "description": "Hyoscyamine may increase the arrhythmogenic activities of Disopyramide"
                    },
                    {
                        "drugbank-id": "DB00308",
                        "description": "Hyoscyamine may increase the arrhythmogenic activities of Ibutilide"
                    },
                    {
                        "drugbank-id": "DB00489",
                        "description": "Hyoscyamine may increase the arrhythmogenic activities of Sotalol"
                    },
                    {
                        "drugbank-id": "DB00908",
                        "description": "Hyoscyamine may increase the arrhythmogenic activities of Quinidine"
                    },
                    {
                        "drugbank-id": "DB01035",
                        "description": "Hyoscyamine may increase the arrhythmogenic activities of Procainamide"
                    },
                    {
                        "drugbank-id": "DB01244",
                        "description": "Hyoscyamine may increase the arrhythmogenic activities of Bepridil"
                    },
                    {
                        "drugbank-id": "DB04855",
                        "description": "Hyoscyamine may increase the arrhythmogenic activities of Dronedarone"
                    },
                    {
                        "drugbank-id": "DB13725",
                        "description": "Hyoscyamine may increase the arrhythmogenic activities of Terodiline"
                    },
                    {
                        "drugbank-id": "DB00187",
                        "description": "Esmolol may increase the arrhythmogenic activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00270",
                        "description": "Isradipine may increase the arrhythmogenic activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00373",
                        "description": "Timolol may increase the arrhythmogenic activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00381",
                        "description": "Amlodipine may increase the arrhythmogenic activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00390",
                        "description": "Digoxin may increase the arrhythmogenic activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00661",
                        "description": "Hyoscyamine may increase the arrhythmogenic activities of Verapamil"
                    },
                    {
                        "drugbank-id": "DB00678",
                        "description": "Hyoscyamine may increase the arrhythmogenic activities of Losartan"
                    },
                    {
                        "drugbank-id": "DB01023",
                        "description": "Hyoscyamine may increase the arrhythmogenic activities of Felodipine"
                    },
                    {
                        "drugbank-id": "DB01054",
                        "description": "Hyoscyamine may increase the arrhythmogenic activities of Nitrendipine"
                    },
                    {
                        "drugbank-id": "DB01074",
                        "description": "Hyoscyamine may increase the arrhythmogenic activities of Perhexiline"
                    },
                    {
                        "drugbank-id": "DB01158",
                        "description": "Hyoscyamine may increase the arrhythmogenic activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB01228",
                        "description": "Hyoscyamine may increase the arrhythmogenic activities of Encainide"
                    },
                    {
                        "drugbank-id": "DB01396",
                        "description": "Hyoscyamine may increase the arrhythmogenic activities of Digitoxin"
                    },
                    {
                        "drugbank-id": "DB01426",
                        "description": "Hyoscyamine may increase the arrhythmogenic activities of Ajmaline"
                    },
                    {
                        "drugbank-id": "DB04846",
                        "description": "Hyoscyamine may increase the arrhythmogenic activities of Celiprolol"
                    },
                    {
                        "drugbank-id": "DB06217",
                        "description": "Hyoscyamine may increase the arrhythmogenic activities of Vernakalant"
                    },
                    {
                        "drugbank-id": "DB06468",
                        "description": "Hyoscyamine may increase the arrhythmogenic activities of Cariporide"
                    },
                    {
                        "drugbank-id": "DB08808",
                        "description": "Hyoscyamine may increase the arrhythmogenic activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB09090",
                        "description": "Hyoscyamine may increase the arrhythmogenic activities of Pinaverium"
                    },
                    {
                        "drugbank-id": "DB09229",
                        "description": "Hyoscyamine may increase the arrhythmogenic activities of Aranidipine"
                    },
                    {
                        "drugbank-id": "DB09235",
                        "description": "Hyoscyamine may increase the arrhythmogenic activities of Efonidipine"
                    },
                    {
                        "drugbank-id": "DB09236",
                        "description": "Hyoscyamine may increase the arrhythmogenic activities of Lacidipine"
                    },
                    {
                        "drugbank-id": "DB09239",
                        "description": "Hyoscyamine may increase the arrhythmogenic activities of Niguldipine"
                    },
                    {
                        "drugbank-id": "DB11770",
                        "description": "Hyoscyamine may increase the arrhythmogenic activities of Talinolol"
                    },
                    {
                        "drugbank-id": "DB11785",
                        "description": "Hyoscyamine may increase the arrhythmogenic activities of Anisodamine"
                    },
                    {
                        "drugbank-id": "DB12712",
                        "description": "Hyoscyamine may increase the arrhythmogenic activities of Pilsicainide"
                    },
                    {
                        "drugbank-id": "DB12766",
                        "description": "Hyoscyamine may increase the arrhythmogenic activities of Cicletanine"
                    },
                    {
                        "drugbank-id": "DB12923",
                        "description": "Hyoscyamine may increase the arrhythmogenic activities of Gallopamil"
                    },
                    {
                        "drugbank-id": "DB13358",
                        "description": "Hyoscyamine may increase the arrhythmogenic activities of Cibenzoline"
                    },
                    {
                        "drugbank-id": "DB13488",
                        "description": "Hyoscyamine may increase the arrhythmogenic activities of Bencyclane"
                    },
                    {
                        "drugbank-id": "DB13555",
                        "description": "Hyoscyamine may increase the arrhythmogenic activities of Prajmaline"
                    },
                    {
                        "drugbank-id": "DB13651",
                        "description": "Hyoscyamine may increase the arrhythmogenic activities of Lorajmine"
                    },
                    {
                        "drugbank-id": "DB13691",
                        "description": "Hyoscyamine may increase the arrhythmogenic activities of Acetyldigoxin"
                    },
                    {
                        "drugbank-id": "DB13766",
                        "description": "Hyoscyamine may increase the arrhythmogenic activities of Lidoflazine"
                    },
                    {
                        "drugbank-id": "DB06152",
                        "description": "Hyoscyamine may increase the arrhythmogenic activities of Nylidrin"
                    },
                    {
                        "drugbank-id": "DB06694",
                        "description": "Hyoscyamine may increase the arrhythmogenic activities of Xylometazoline"
                    },
                    {
                        "drugbank-id": "DB00653",
                        "description": "Hyoscyamine may increase the arrhythmogenic activities of Magnesium sulfate"
                    },
                    {
                        "drugbank-id": "DB00332",
                        "description": "The risk or severity of adverse effects can be increased when Hyoscyamine is combined with Ipratropium"
                    },
                    {
                        "drugbank-id": "DB00470",
                        "description": "The risk or severity of Tachycardia and drowsiness can be increased when Hyoscyamine is combined with Dronabinol"
                    },
                    {
                        "drugbank-id": "DB00486",
                        "description": "The risk or severity of Tachycardia and drowsiness can be increased when Hyoscyamine is combined with Nabilone"
                    },
                    {
                        "drugbank-id": "DB05077",
                        "description": "The risk or severity of Tachycardia and drowsiness can be increased when Hyoscyamine is combined with SLV319"
                    },
                    {
                        "drugbank-id": "DB06155",
                        "description": "The risk or severity of Tachycardia and drowsiness can be increased when Hyoscyamine is combined with Rimonabant"
                    },
                    {
                        "drugbank-id": "DB06624",
                        "description": "The risk or severity of Tachycardia and drowsiness can be increased when Hyoscyamine is combined with Taranabant"
                    },
                    {
                        "drugbank-id": "DB09061",
                        "description": "The risk or severity of Tachycardia and drowsiness can be increased when Hyoscyamine is combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB11903",
                        "description": "The risk or severity of Tachycardia and drowsiness can be increased when Hyoscyamine is combined with GW842166"
                    },
                    {
                        "drugbank-id": "DB12193",
                        "description": "The risk or severity of Tachycardia and drowsiness can be increased when Hyoscyamine is combined with Ajulemic acid"
                    },
                    {
                        "drugbank-id": "DB12649",
                        "description": "The risk or severity of Tachycardia and drowsiness can be increased when Hyoscyamine is combined with Ibipinabant"
                    },
                    {
                        "drugbank-id": "DB13070",
                        "description": "The risk or severity of Tachycardia and drowsiness can be increased when Hyoscyamine is combined with Surinabant"
                    },
                    {
                        "drugbank-id": "DB14011",
                        "description": "The risk or severity of Tachycardia and drowsiness can be increased when Hyoscyamine is combined with Nabiximols"
                    },
                    {
                        "drugbank-id": "DB14043",
                        "description": "The risk or severity of Tachycardia and drowsiness can be increased when Hyoscyamine is combined with Palmidrol"
                    },
                    {
                        "drugbank-id": "DB14737",
                        "description": "The risk or severity of Tachycardia and drowsiness can be increased when Hyoscyamine is combined with Cannabinol"
                    },
                    {
                        "drugbank-id": "DB00082",
                        "description": "The therapeutic efficacy of Hyoscyamine can be decreased when used in combination with Pegvisomant"
                    },
                    {
                        "drugbank-id": "DB00382",
                        "description": "The therapeutic efficacy of Hyoscyamine can be decreased when used in combination with Tacrine"
                    },
                    {
                        "drugbank-id": "DB00392",
                        "description": "The therapeutic efficacy of Hyoscyamine can be decreased when used in combination with Profenamine"
                    },
                    {
                        "drugbank-id": "DB00515",
                        "description": "The therapeutic efficacy of Hyoscyamine can be decreased when used in combination with Cisplatin"
                    },
                    {
                        "drugbank-id": "DB00527",
                        "description": "The therapeutic efficacy of Hyoscyamine can be decreased when used in combination with Cinchocaine"
                    },
                    {
                        "drugbank-id": "DB00545",
                        "description": "The therapeutic efficacy of Hyoscyamine can be decreased when used in combination with Pyridostigmine"
                    },
                    {
                        "drugbank-id": "DB00585",
                        "description": "The therapeutic efficacy of Hyoscyamine can be decreased when used in combination with Nizatidine"
                    },
                    {
                        "drugbank-id": "DB00677",
                        "description": "The therapeutic efficacy of Hyoscyamine can be decreased when used in combination with Isoflurophate"
                    },
                    {
                        "drugbank-id": "DB00711",
                        "description": "The therapeutic efficacy of Hyoscyamine can be decreased when used in combination with Diethylcarbamazine"
                    },
                    {
                        "drugbank-id": "DB00888",
                        "description": "The therapeutic efficacy of Hyoscyamine can be decreased when used in combination with Mechlorethamine"
                    },
                    {
                        "drugbank-id": "DB00944",
                        "description": "The therapeutic efficacy of Hyoscyamine can be decreased when used in combination with Demecarium"
                    },
                    {
                        "drugbank-id": "DB00981",
                        "description": "The therapeutic efficacy of Hyoscyamine can be decreased when used in combination with Physostigmine"
                    },
                    {
                        "drugbank-id": "DB00989",
                        "description": "The therapeutic efficacy of Hyoscyamine can be decreased when used in combination with Rivastigmine"
                    },
                    {
                        "drugbank-id": "DB01010",
                        "description": "The therapeutic efficacy of Hyoscyamine can be decreased when used in combination with Edrophonium"
                    },
                    {
                        "drugbank-id": "DB01043",
                        "description": "The therapeutic efficacy of Hyoscyamine can be decreased when used in combination with Memantine"
                    },
                    {
                        "drugbank-id": "DB01122",
                        "description": "The therapeutic efficacy of Hyoscyamine can be decreased when used in combination with Ambenonium"
                    },
                    {
                        "drugbank-id": "DB01381",
                        "description": "The therapeutic efficacy of Hyoscyamine can be decreased when used in combination with Ginkgo biloba"
                    },
                    {
                        "drugbank-id": "DB01400",
                        "description": "The therapeutic efficacy of Hyoscyamine can be decreased when used in combination with Neostigmine"
                    },
                    {
                        "drugbank-id": "DB01408",
                        "description": "The therapeutic efficacy of Hyoscyamine can be decreased when used in combination with Bambuterol"
                    },
                    {
                        "drugbank-id": "DB02365",
                        "description": "The therapeutic efficacy of Hyoscyamine can be decreased when used in combination with 1 10 Phenanthroline"
                    },
                    {
                        "drugbank-id": "DB04572",
                        "description": "The therapeutic efficacy of Hyoscyamine can be decreased when used in combination with Thiotepa"
                    },
                    {
                        "drugbank-id": "DB04864",
                        "description": "The therapeutic efficacy of Hyoscyamine can be decreased when used in combination with Huperzine A"
                    },
                    {
                        "drugbank-id": "DB04892",
                        "description": "The therapeutic efficacy of Hyoscyamine can be decreased when used in combination with Phenserine"
                    },
                    {
                        "drugbank-id": "DB05386",
                        "description": "The therapeutic efficacy of Hyoscyamine can be decreased when used in combination with Regramostim"
                    },
                    {
                        "drugbank-id": "DB06692",
                        "description": "The therapeutic efficacy of Hyoscyamine can be decreased when used in combination with Aprotinin"
                    },
                    {
                        "drugbank-id": "DB06756",
                        "description": "The therapeutic efficacy of Hyoscyamine can be decreased when used in combination with Glycine betaine"
                    },
                    {
                        "drugbank-id": "DB06774",
                        "description": "The therapeutic efficacy of Hyoscyamine can be decreased when used in combination with Capsaicin"
                    },
                    {
                        "drugbank-id": "DB11473",
                        "description": "The therapeutic efficacy of Hyoscyamine can be decreased when used in combination with Metrifonate"
                    },
                    {
                        "drugbank-id": "DB12482",
                        "description": "The therapeutic efficacy of Hyoscyamine can be decreased when used in combination with Acotiamide"
                    },
                    {
                        "drugbank-id": "DB13058",
                        "description": "The therapeutic efficacy of Hyoscyamine can be decreased when used in combination with Methanesulfonyl Fluoride"
                    },
                    {
                        "drugbank-id": "DB13495",
                        "description": "The therapeutic efficacy of Hyoscyamine can be decreased when used in combination with Paraoxon"
                    },
                    {
                        "drugbank-id": "DB13503",
                        "description": "The therapeutic efficacy of Hyoscyamine can be decreased when used in combination with Tyrothricin"
                    },
                    {
                        "drugbank-id": "DB13668",
                        "description": "The therapeutic efficacy of Hyoscyamine can be decreased when used in combination with Ipidacrine"
                    },
                    {
                        "drugbank-id": "DB13694",
                        "description": "The therapeutic efficacy of Hyoscyamine can be decreased when used in combination with Distigmine"
                    },
                    {
                        "drugbank-id": "DB14031",
                        "description": "The therapeutic efficacy of Hyoscyamine can be decreased when used in combination with Tretamine"
                    },
                    {
                        "drugbank-id": "DB15317",
                        "description": "The therapeutic efficacy of Hyoscyamine can be decreased when used in combination with Posiphen"
                    },
                    {
                        "drugbank-id": "DB02845",
                        "description": "The therapeutic efficacy of Hyoscyamine can be decreased when used in combination with Methylphosphinic Acid"
                    },
                    {
                        "drugbank-id": "DB00581",
                        "description": "The therapeutic efficacy of Lactulose can be decreased when used in combination with Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB01046",
                        "description": "The therapeutic efficacy of Lubiprostone can be decreased when used in combination with Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB01079",
                        "description": "The therapeutic efficacy of Tegaserod can be decreased when used in combination with Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB01378",
                        "description": "The therapeutic efficacy of Magnesium cation can be decreased when used in combination with Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB01593",
                        "description": "The therapeutic efficacy of Zinc can be decreased when used in combination with Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB01638",
                        "description": "The therapeutic efficacy of Sorbitol can be decreased when used in combination with Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB04816",
                        "description": "The therapeutic efficacy of Dantron can be decreased when used in combination with Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB04823",
                        "description": "The therapeutic efficacy of Oxyphenisatin can be decreased when used in combination with Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB04824",
                        "description": "The therapeutic efficacy of Phenolphthalein can be decreased when used in combination with Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB06480",
                        "description": "The therapeutic efficacy of Prucalopride can be decreased when used in combination with Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB07715",
                        "description": "The therapeutic efficacy of Emodin can be decreased when used in combination with Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB08890",
                        "description": "The therapeutic efficacy of Linaclotide can be decreased when used in combination with Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB09020",
                        "description": "The therapeutic efficacy of Bisacodyl can be decreased when used in combination with Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB09219",
                        "description": "The therapeutic efficacy of Bisoxatin can be decreased when used in combination with Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB09268",
                        "description": "The therapeutic efficacy of Picosulfuric acid can be decreased when used in combination with Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB09287",
                        "description": "The therapeutic efficacy of Polyethylene glycol can be decreased when used in combination with Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB09311",
                        "description": "The therapeutic efficacy of Polycarbophil can be decreased when used in combination with Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB09413",
                        "description": "The therapeutic efficacy of Monopotassium phosphate can be decreased when used in combination with Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB09414",
                        "description": "The therapeutic efficacy of Dipotassium phosphate can be decreased when used in combination with Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB09449",
                        "description": "The therapeutic efficacy of Sodium phosphate monobasic can be decreased when used in combination with Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB09462",
                        "description": "The therapeutic efficacy of Glycerin can be decreased when used in combination with Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB09472",
                        "description": "The therapeutic efficacy of Sodium sulfate can be decreased when used in combination with Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB09484",
                        "description": "The therapeutic efficacy of Sodium fluorophosphate can be decreased when used in combination with Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB11057",
                        "description": "The therapeutic efficacy of Mineral oil can be decreased when used in combination with Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB11059",
                        "description": "The therapeutic efficacy of Carboxymethylcellulose can be decreased when used in combination with Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB11089",
                        "description": "The therapeutic efficacy of Docusate can be decreased when used in combination with Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB11097",
                        "description": "The therapeutic efficacy of Plantago seed can be decreased when used in combination with Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB11110",
                        "description": "The therapeutic efficacy of Magnesium citrate can be decreased when used in combination with Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB11113",
                        "description": "The therapeutic efficacy of Castor oil can be decreased when used in combination with Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB11189",
                        "description": "The therapeutic efficacy of Magnesium glycinate can be decreased when used in combination with Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB11228",
                        "description": "The therapeutic efficacy of Methylcellulose can be decreased when used in combination with Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB11365",
                        "description": "The therapeutic efficacy of Sennosides can be decreased when used in combination with Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB12942",
                        "description": "The therapeutic efficacy of Lactitol can be decreased when used in combination with Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB13170",
                        "description": "The therapeutic efficacy of Plecanatide can be decreased when used in combination with Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB13526",
                        "description": "The therapeutic efficacy of Pentaerithrityl can be decreased when used in combination with Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB13707",
                        "description": "The therapeutic efficacy of Sodium tartrate can be decreased when used in combination with Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB14232",
                        "description": "The therapeutic efficacy of Deacetylbisacodyl can be decreased when used in combination with Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB14482",
                        "description": "The therapeutic efficacy of Sodium ascorbate can be decreased when used in combination with Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB14499",
                        "description": "The therapeutic efficacy of Potassium sulfate can be decreased when used in combination with Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB14502",
                        "description": "The therapeutic efficacy of Sodium phosphate dibasic can be decreased when used in combination with Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB14503",
                        "description": "The therapeutic efficacy of Sodium phosphate monobasic unspecified form can be decreased when used in combination with Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB14504",
                        "description": "The therapeutic efficacy of Sodium phosphate dibasic unspecified form can be decreased when used in combination with Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB14513",
                        "description": "The therapeutic efficacy of Magnesium can be decreased when used in combination with Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB14585",
                        "description": "The therapeutic efficacy of Plantago ovata seed can be decreased when used in combination with Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB14627",
                        "description": "The therapeutic efficacy of Oxyphenisatin acetate can be decreased when used in combination with Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB14684",
                        "description": "The therapeutic efficacy of Calcium polycarbophil can be decreased when used in combination with Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB14963",
                        "description": "The therapeutic efficacy of Konjac mannan can be decreased when used in combination with Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB15477",
                        "description": "The therapeutic efficacy of Alloin can be decreased when used in combination with Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB15478",
                        "description": "The therapeutic efficacy of Frangula purshiana bark can be decreased when used in combination with Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB11622",
                        "description": "The therapeutic efficacy of Dehydrocholic acid can be decreased when used in combination with Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB14516",
                        "description": "The therapeutic efficacy of Sodium cation can be decreased when used in combination with Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB14546",
                        "description": "The therapeutic efficacy of Sulfate ion can be decreased when used in combination with Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00477",
                        "description": "Chlorpromazine may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00483",
                        "description": "Gallamine triethiodide may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00508",
                        "description": "Triflupromazine may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00721",
                        "description": "Procaine may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00805",
                        "description": "Minaprine may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00941",
                        "description": "Hexafluronium may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB01199",
                        "description": "Tubocurarine may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB01221",
                        "description": "Ketamine may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB01245",
                        "description": "Decamethonium may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB01337",
                        "description": "Pancuronium may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB01338",
                        "description": "Pipecuronium may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00150",
                        "description": "Tryptophan may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00176",
                        "description": "Fluvoxamine may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00181",
                        "description": "Baclofen may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00182",
                        "description": "Amphetamine may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00186",
                        "description": "Lorazepam may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00189",
                        "description": "Ethchlorvynol may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00202",
                        "description": "Succinylcholine may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00206",
                        "description": "Reserpine may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00216",
                        "description": "Eletriptan may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00228",
                        "description": "Enflurane may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00231",
                        "description": "Temazepam may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00234",
                        "description": "Reboxetine may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00237",
                        "description": "Butabarbital may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00241",
                        "description": "Butalbital may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00247",
                        "description": "Methysergide may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00248",
                        "description": "Cabergoline may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00252",
                        "description": "Phenytoin may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00268",
                        "description": "Ropinirole may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00285",
                        "description": "Venlafaxine may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00289",
                        "description": "Atomoxetine may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00292",
                        "description": "Etomidate may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00306",
                        "description": "Talbutal may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00312",
                        "description": "Pentobarbital may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00315",
                        "description": "Zolmitriptan may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00320",
                        "description": "Dihydroergotamine may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00323",
                        "description": "Tolcapone may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00334",
                        "description": "Olanzapine may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00341",
                        "description": "Cetirizine may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00344",
                        "description": "Protriptyline may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00349",
                        "description": "Clobazam may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00356",
                        "description": "Chlorzoxazone may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00366",
                        "description": "Doxylamine may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00370",
                        "description": "Mirtazapine may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00371",
                        "description": "Meprobamate may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00372",
                        "description": "Thiethylperazine may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00377",
                        "description": "Palonosetron may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00395",
                        "description": "Carisoprodol may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00402",
                        "description": "Eszopiclone may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00404",
                        "description": "Alprazolam may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00405",
                        "description": "Dexbrompheniramine may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00408",
                        "description": "Loxapine may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00409",
                        "description": "Remoxipride may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00416",
                        "description": "Metocurine iodide may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00418",
                        "description": "Secobarbital may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00423",
                        "description": "Methocarbamol may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00425",
                        "description": "Zolpidem may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00427",
                        "description": "Triprolidine may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00434",
                        "description": "Cyproheptadine may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00463",
                        "description": "Metharbital may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00474",
                        "description": "Methohexital may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00475",
                        "description": "Chlordiazepoxide may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00476",
                        "description": "Duloxetine may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00494",
                        "description": "Entacapone may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00514",
                        "description": "Dextromethorphan may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00532",
                        "description": "Mephenytoin may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00540",
                        "description": "Nortriptyline may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00543",
                        "description": "Amoxapine may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00546",
                        "description": "Adinazolam may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00564",
                        "description": "Carbamazepine may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00565",
                        "description": "Cisatracurium may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00574",
                        "description": "Fenfluramine may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00575",
                        "description": "Clonidine may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00579",
                        "description": "Mazindol may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00588",
                        "description": "Fluticasone propionate may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00589",
                        "description": "Lisuride may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00599",
                        "description": "Thiopental may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00601",
                        "description": "Linezolid may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00614",
                        "description": "Furazolidone may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00617",
                        "description": "Paramethadione may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00623",
                        "description": "Fluphenazine may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00628",
                        "description": "Clorazepic acid may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00633",
                        "description": "Dexmedetomidine may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00645",
                        "description": "Dyclonine may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00660",
                        "description": "Metaxalone may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00662",
                        "description": "Trimethobenzamide may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00669",
                        "description": "Sumatriptan may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00683",
                        "description": "Midazolam may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00690",
                        "description": "Flurazepam may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00696",
                        "description": "Ergotamine may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00697",
                        "description": "Tizanidine may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00714",
                        "description": "Apomorphine may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00715",
                        "description": "Paroxetine may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00726",
                        "description": "Trimipramine may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00728",
                        "description": "Rocuronium may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00732",
                        "description": "Atracurium besylate may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00734",
                        "description": "Risperidone may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00737",
                        "description": "Meclizine may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00740",
                        "description": "Riluzole may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00752",
                        "description": "Tranylcypromine may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00753",
                        "description": "Isoflurane may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00754",
                        "description": "Ethotoin may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00771",
                        "description": "Clidinium may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00776",
                        "description": "Oxcarbazepine may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00777",
                        "description": "Propiomazine may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00780",
                        "description": "Phenelzine may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00794",
                        "description": "Primidone may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00801",
                        "description": "Halazepam may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00818",
                        "description": "Propofol may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00819",
                        "description": "Acetazolamide may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00829",
                        "description": "Diazepam may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00831",
                        "description": "Trifluoperazine may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00832",
                        "description": "Phensuximide may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00835",
                        "description": "Brompheniramine may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00837",
                        "description": "Progabide may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00842",
                        "description": "Oxazepam may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00849",
                        "description": "Methylphenobarbital may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00850",
                        "description": "Perphenazine may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00865",
                        "description": "Benzphetamine may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00897",
                        "description": "Triazolam may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00898",
                        "description": "Ethanol may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00906",
                        "description": "Tiagabine may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00918",
                        "description": "Almotriptan may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00924",
                        "description": "Cyclobenzaprine may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00934",
                        "description": "Maprotiline may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00937",
                        "description": "Diethylpropion may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00949",
                        "description": "Felbamate may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00952",
                        "description": "Naratriptan may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00953",
                        "description": "Rizatriptan may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00960",
                        "description": "Pindolol may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00962",
                        "description": "Zaleplon may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00969",
                        "description": "Alosetron may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00972",
                        "description": "Azelastine may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00980",
                        "description": "Ramelteon may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00996",
                        "description": "Gabapentin may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00998",
                        "description": "Frovatriptan may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB01018",
                        "description": "Guanfacine may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB01028",
                        "description": "Methoxyflurane may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB01037",
                        "description": "Selegiline may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB01041",
                        "description": "Thalidomide may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB01049",
                        "description": "Ergoloid mesylate may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB01063",
                        "description": "Acetophenazine may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB01065",
                        "description": "Melatonin may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB01068",
                        "description": "Clonazepam may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB01069",
                        "description": "Promethazine may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB01075",
                        "description": "Diphenhydramine may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB01080",
                        "description": "Vigabatrin may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB01104",
                        "description": "Sertraline may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB01105",
                        "description": "Sibutramine may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB01106",
                        "description": "Levocabastine may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB01107",
                        "description": "Methyprylon may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB01121",
                        "description": "Phenacemide may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB01135",
                        "description": "Doxacurium may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB01142",
                        "description": "Doxepin may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB01149",
                        "description": "Nefazodone may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB01151",
                        "description": "Desipramine may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB01154",
                        "description": "Thiamylal may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB01156",
                        "description": "Bupropion may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB01159",
                        "description": "Halothane may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB01168",
                        "description": "Procarbazine may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB01171",
                        "description": "Moclobemide may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB01173",
                        "description": "Orphenadrine may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB01176",
                        "description": "Cyclizine may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB01178",
                        "description": "Chlormezanone may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB01186",
                        "description": "Pergolide may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB01189",
                        "description": "Desflurane may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB01198",
                        "description": "Zopiclone may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB01200",
                        "description": "Bromocriptine may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB01202",
                        "description": "Levetiracetam may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB01215",
                        "description": "Estazolam may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB01219",
                        "description": "Dantrolene may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB01226",
                        "description": "Mivacurium may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB01236",
                        "description": "Sevoflurane may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB01238",
                        "description": "Aripiprazole may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB01239",
                        "description": "Chlorprothixene may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB01246",
                        "description": "Alimemazine may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB01247",
                        "description": "Isocarboxazid may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB01253",
                        "description": "Ergometrine may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB01320",
                        "description": "Fosphenytoin may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB01323",
                        "description": "St John s Wort may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB01336",
                        "description": "Metocurine may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB01339",
                        "description": "Vecuronium may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB01351",
                        "description": "Amobarbital may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB01352",
                        "description": "Aprobarbital may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB01353",
                        "description": "Butobarbital may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB01354",
                        "description": "Heptabarbital may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB01355",
                        "description": "Hexobarbital may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB01359",
                        "description": "Penbutolol may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB01367",
                        "description": "Rasagiline may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB01392",
                        "description": "Yohimbine may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB01403",
                        "description": "Methotrimeprazine may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB01437",
                        "description": "Glutethimide may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB01440",
                        "description": "gamma Hydroxybutyric acid may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB01442",
                        "description": "MMDA may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB01445",
                        "description": "Bufotenine may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB01454",
                        "description": "Midomafetamine may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB01463",
                        "description": "Fencamfamin may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB01472",
                        "description": "4 Methoxyamphetamine may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB01483",
                        "description": "Barbital may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB01484",
                        "description": "4 Bromo 2 5 dimethoxyamphetamine may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB01488",
                        "description": "Dimethyltryptamine may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB01489",
                        "description": "Camazepam may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB01495",
                        "description": "Dichloralphenazone may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB01501",
                        "description": "Difenoxin may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB01509",
                        "description": "Tenamfetamine may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB01511",
                        "description": "Delorazepam may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB01534",
                        "description": "Chlorhexadol may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB01544",
                        "description": "Flunitrazepam may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB01545",
                        "description": "Ethyl loflazepate may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB01547",
                        "description": "Drotebanol may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB01553",
                        "description": "Cloxazolam may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB01558",
                        "description": "Bromazepam may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB01559",
                        "description": "Clotiazepam may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB01560",
                        "description": "Cathinone may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB01563",
                        "description": "Chloral hydrate may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB01567",
                        "description": "Fludiazepam may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB01577",
                        "description": "Metamfetamine may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB01587",
                        "description": "Ketazolam may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB01588",
                        "description": "Prazepam may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB01589",
                        "description": "Quazepam may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB01594",
                        "description": "Cinolazepam may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB01595",
                        "description": "Nitrazepam may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB01608",
                        "description": "Periciazine may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB01614",
                        "description": "Acepromazine may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB01616",
                        "description": "Alverine may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB01618",
                        "description": "Molindone may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB01621",
                        "description": "Pipotiazine may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB01622",
                        "description": "Thioproperazine may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB01623",
                        "description": "Thiothixene may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB01626",
                        "description": "Pargyline may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB01954",
                        "description": "Rolipram may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB02207",
                        "description": "7 Nitroindazole may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB02234",
                        "description": "S Ethylisothiourea may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB02852",
                        "description": "Domoic Acid may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB02959",
                        "description": "Oxitriptan may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB03575",
                        "description": "Phencyclidine may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB04017",
                        "description": "Clorgiline may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB04165",
                        "description": "Valpromide may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB04325",
                        "description": "Phenethylamine may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB04599",
                        "description": "Aniracetam may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB04818",
                        "description": "Iproniazid may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB04819",
                        "description": "Methapyrilene may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB04820",
                        "description": "Nialamide may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB04821",
                        "description": "Nomifensine may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB04827",
                        "description": "Urethane may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB04829",
                        "description": "Lysergic acid diethylamide may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB04832",
                        "description": "Zimelidine may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB04833",
                        "description": "Methaqualone may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB04834",
                        "description": "Rapacuronium may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB04836",
                        "description": "Amineptine may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB04871",
                        "description": "Lorcaserin may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB04872",
                        "description": "Osanetant may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB04884",
                        "description": "Dapoxetine may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB04885",
                        "description": "Cilansetron may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB04888",
                        "description": "Bifeprunox may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB04896",
                        "description": "Milnacipran may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB04903",
                        "description": "Pagoclone may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB04908",
                        "description": "Flibanserin may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB04917",
                        "description": "Renzapride may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB04953",
                        "description": "Ezogabine may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB05227",
                        "description": "APD791 may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB05232",
                        "description": "Tetrodotoxin may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB05271",
                        "description": "Rotigotine may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB05316",
                        "description": "Pimavanserin may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB05541",
                        "description": "Brivaracetam may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB05542",
                        "description": "Naronapride may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB05562",
                        "description": "Naluzotan may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB05607",
                        "description": "PRX 08066 may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB05687",
                        "description": "BL 1020 may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB05710",
                        "description": "Gantacurium may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB06016",
                        "description": "Cariprazine may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB06077",
                        "description": "Lumateperone may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB06109",
                        "description": "YKP 1358 may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB06144",
                        "description": "Sertindole may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB06153",
                        "description": "Pizotifen may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB06201",
                        "description": "Rufinamide may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB06218",
                        "description": "Lacosamide may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB06264",
                        "description": "Tolperisone may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB06282",
                        "description": "Levocetirizine may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB06288",
                        "description": "Amisulpride may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB06458",
                        "description": "Remacemide may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB06470",
                        "description": "Clomethiazole may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB06512",
                        "description": "Deramciclane may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB06527",
                        "description": "Tramiprosate may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB06529",
                        "description": "Ocinaplon may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB06554",
                        "description": "Gaboxadol may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB06579",
                        "description": "Adipiplon may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB06582",
                        "description": "Dextofisopam may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB06594",
                        "description": "Agomelatine may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB06654",
                        "description": "Safinamide may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB06660",
                        "description": "Saredutant may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB06678",
                        "description": "Esmirtazapine may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB06684",
                        "description": "Vilazodone may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB06690",
                        "description": "Nitrous oxide may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB06691",
                        "description": "Mepyramine may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB06700",
                        "description": "Desvenlafaxine may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB06701",
                        "description": "Dexmethylphenidate may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB06716",
                        "description": "Fospropofol may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB06731",
                        "description": "Seproxetine may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB06753",
                        "description": "Triclofos may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB06770",
                        "description": "Benzyl alcohol may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB06797",
                        "description": "Mebutamate may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB08059",
                        "description": "Wortmannin may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB08329",
                        "description": "Sulthiame may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB08550",
                        "description": "7 8 Dichloro 1 2 3 4 tetrahydroisoquinoline may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB08810",
                        "description": "Cinitapride may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB08811",
                        "description": "Tofisopam may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB08815",
                        "description": "Lurasidone may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB08839",
                        "description": "Serotonin may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB08872",
                        "description": "Gabapentin enacarbil may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB08883",
                        "description": "Perampanel may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB08892",
                        "description": "Arbaclofen Placarbil may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB08910",
                        "description": "Pomalidomide may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB08918",
                        "description": "Levomilnacipran may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB08922",
                        "description": "Perospirone may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB08927",
                        "description": "Amperozide may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB08953",
                        "description": "Indalpine may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB08954",
                        "description": "Ifenprodil may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB08960",
                        "description": "Hexamethonium may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB08986",
                        "description": "Etifoxine may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB08996",
                        "description": "Dimetacrine may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB09000",
                        "description": "Cyamemazine may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB09001",
                        "description": "Barbexaclone may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB09011",
                        "description": "Beclamide may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB09014",
                        "description": "Captodiame may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB09017",
                        "description": "Brotizolam may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB09021",
                        "description": "Benzoctamine may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB09023",
                        "description": "Benactyzine may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB09034",
                        "description": "Suvorexant may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB09068",
                        "description": "Vortioxetine may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB09071",
                        "description": "Tasimelteon may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB09072",
                        "description": "Sodium oxybate may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB09117",
                        "description": "Paraldehyde may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB09118",
                        "description": "Stiripentol may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB09119",
                        "description": "Eslicarbazepine acetate may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB09128",
                        "description": "Brexpiprazole may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB09166",
                        "description": "Etizolam may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB09167",
                        "description": "Dosulepin may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB09184",
                        "description": "Edivoxetine may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB09185",
                        "description": "Viloxazine may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB09186",
                        "description": "Nisoxetine may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB09187",
                        "description": "Lortalamine may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB09190",
                        "description": "Talopram may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB09194",
                        "description": "Etoperidone may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB09223",
                        "description": "Blonanserin may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB09225",
                        "description": "Zotepine may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB09226",
                        "description": "Brilaroxazine may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB09241",
                        "description": "Methylene blue may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB09243",
                        "description": "Hydracarbazine may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB09244",
                        "description": "Pirlindole may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB09245",
                        "description": "Toloxatone may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB09246",
                        "description": "Benmoxin may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB09247",
                        "description": "Iproclozide may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB09248",
                        "description": "Mebanazine may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB09249",
                        "description": "Octamoxin may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB09250",
                        "description": "Pheniprazine may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB09251",
                        "description": "Phenoxypropazine may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB09252",
                        "description": "Pivhydrazine may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB09253",
                        "description": "Safrazine may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB09254",
                        "description": "Caroxazone may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB09286",
                        "description": "Pipamperone may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB09289",
                        "description": "Tianeptine may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB09307",
                        "description": "Oxaprotiline may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB11156",
                        "description": "Pyrantel may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB11371",
                        "description": "Alfaxalone may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB11376",
                        "description": "Azaperone may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB11400",
                        "description": "Doramectin may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB11428",
                        "description": "Medetomidine may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB11477",
                        "description": "Xylazine may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB11540",
                        "description": "Propiopromazine may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB11543",
                        "description": "Romifidine may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB11549",
                        "description": "Tiletamine may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB11552",
                        "description": "Tricaine may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB11555",
                        "description": "Zolazepam may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB11556",
                        "description": "Detomidine may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB11582",
                        "description": "Thiocolchicoside may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB11664",
                        "description": "Psilocybin may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB11675",
                        "description": "Mosapride may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB11686",
                        "description": "Iferanserin may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB11732",
                        "description": "Lasmiditan may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB11755",
                        "description": "Tetrahydrocannabivarin may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB11823",
                        "description": "Esketamine may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB11859",
                        "description": "Brexanolone may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB11868",
                        "description": "Etiracetam may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB11889",
                        "description": "Lanicemine may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB11957",
                        "description": "Idalopirdine may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB12071",
                        "description": "Vabicaserin may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB12105",
                        "description": "Imagabalin may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB12110",
                        "description": "m Chlorophenylpiperazine may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB12111",
                        "description": "MK 212 may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB12163",
                        "description": "Sarpogrelate may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB12177",
                        "description": "Eplivanserin may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB12184",
                        "description": "Gepirone may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB12229",
                        "description": "Cerlapirdine may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB12273",
                        "description": "Ecopipam may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB12308",
                        "description": "Eltanolone may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB12327",
                        "description": "Salvinorin A may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB12338",
                        "description": "Carisbamate may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB12361",
                        "description": "Piclozotan may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB12395",
                        "description": "Esreboxetine may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB12401",
                        "description": "Bromperidol may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB12427",
                        "description": "Orvepitant may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB12465",
                        "description": "Ketanserin may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB12518",
                        "description": "Raclopride may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB12537",
                        "description": "Benzodiazepine may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB12576",
                        "description": "AZD 3043 may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB12590",
                        "description": "Indiplon may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB12661",
                        "description": "Urapidil may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB12693",
                        "description": "Ritanserin may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB12710",
                        "description": "Perazine may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB12725",
                        "description": "TD 8954 may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB12833",
                        "description": "Tandospirone may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB12867",
                        "description": "Benperidol may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB12883",
                        "description": "Eltoprazine may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB12930",
                        "description": "Opipramol may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB12951",
                        "description": "Pivagabine may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB12958",
                        "description": "Prothipendyl may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB12989",
                        "description": "Neosaxitoxin may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB13014",
                        "description": "Hypericin may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB13025",
                        "description": "Tiapride may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB13082",
                        "description": "Nefiracetam may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB13099",
                        "description": "Valnoctamide may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB13114",
                        "description": "Amitriptylinoxide may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB13213",
                        "description": "Butaperazine may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB13219",
                        "description": "Medifoxamine may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB13221",
                        "description": "Apronalide may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB13225",
                        "description": "Dibenzepin may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB13233",
                        "description": "Alaproclate may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB13234",
                        "description": "Propanidid may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB13246",
                        "description": "Quinupramine may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB13253",
                        "description": "Proxibarbal may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB13256",
                        "description": "Clothiapine may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB13295",
                        "description": "Atracurium may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB13303",
                        "description": "Febarbamate may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB13323",
                        "description": "Trichloroethylene may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB13324",
                        "description": "Tetrazepam may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB13331",
                        "description": "Pyrithyldione may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB13335",
                        "description": "Pinazepam may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB13352",
                        "description": "Deanol may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB13354",
                        "description": "Phenprobamate may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB13357",
                        "description": "Styramate may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB13362",
                        "description": "Pheneturide may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB13370",
                        "description": "Bromisoval may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB13377",
                        "description": "Vinbarbital may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB13382",
                        "description": "Chlorproethazine may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB13384",
                        "description": "Melitracen may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB13396",
                        "description": "Neocitrullamon may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB13402",
                        "description": "Acetylglycinamide chloral hydrate may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB13403",
                        "description": "Oxypertine may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB13411",
                        "description": "Lofepramine may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB13414",
                        "description": "Fenyramidol may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB13420",
                        "description": "Thiazinam may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB13437",
                        "description": "Medazepam may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB13455",
                        "description": "Phenibut may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB13457",
                        "description": "Oxaflozane may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB13496",
                        "description": "Iprindole may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB13505",
                        "description": "Emepronium may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB13520",
                        "description": "Metergoline may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB13522",
                        "description": "Mebicar may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB13523",
                        "description": "Veralipride may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB13534",
                        "description": "Gedocarnil may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB13541",
                        "description": "Iprazochrome may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB13550",
                        "description": "Bifemelane may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB13552",
                        "description": "Trifluperidol may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB13554",
                        "description": "Moperone may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB13557",
                        "description": "Thiopropazate may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB13572",
                        "description": "Emylcamate may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB13577",
                        "description": "Allobarbital may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB13584",
                        "description": "Gallamine may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB13588",
                        "description": "Naftidrofuryl may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB13598",
                        "description": "Diethyl ether may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB13601",
                        "description": "Oxiracetam may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB13623",
                        "description": "Fabomotizole may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB13642",
                        "description": "Pridinol may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB13643",
                        "description": "Loprazolam may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB13648",
                        "description": "Alcuronium may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB13662",
                        "description": "Hexapropymate may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB13665",
                        "description": "Fluanisone may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB13676",
                        "description": "Mosapramine may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB13687",
                        "description": "Niaprazine may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB13690",
                        "description": "Vinyl ether may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB13733",
                        "description": "Methylpentynol may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB13737",
                        "description": "Cyclobarbital may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB13745",
                        "description": "Fazadinium bromide may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB13754",
                        "description": "Mephenoxalone may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB13770",
                        "description": "Vinylbital may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB13782",
                        "description": "Imipramine oxide may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB13784",
                        "description": "Dixyrazine may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB13799",
                        "description": "Ethadione may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB13805",
                        "description": "Reposal may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB13817",
                        "description": "Carbromal may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB13837",
                        "description": "Doxefazepam may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB13841",
                        "description": "Clopenthixol may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB13872",
                        "description": "Lormetazepam may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB13875",
                        "description": "Harmaline may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB13876",
                        "description": "Brofaromine may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB13940",
                        "description": "2 5 Dimethoxy 4 ethylthioamphetamine may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB13948",
                        "description": "N 2 hydroxybenzyl 2 5 dimethoxy 4 cyanophenylethylamine may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB13984",
                        "description": "Cyclopropane may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB13993",
                        "description": "MRK 409 may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB14010",
                        "description": "5 methoxy N N dimethyltryptamine may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB14028",
                        "description": "Nordazepam may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB14050",
                        "description": "Cannabidivarin may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB14185",
                        "description": "Aripiprazole lauroxil may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB14509",
                        "description": "Lithium carbonate may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB14575",
                        "description": "Eslicarbazepine may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB14651",
                        "description": "Perphenazine enanthate may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB14672",
                        "description": "Oxazepam acetate may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB14715",
                        "description": "Cinazepam may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB14718",
                        "description": "Pyrazolam may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB14719",
                        "description": "Bentazepam may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB15203",
                        "description": "JNJ 26489112 may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00967",
                        "description": "Hyoscyamine may increase the central nervous system depressant CNS depressant activities of Desloratadine"
                    },
                    {
                        "drugbank-id": "DB11951",
                        "description": "Lemborexant may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB12404",
                        "description": "Remimazolam may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00751",
                        "description": "Epinastine may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00007",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Leuprolide"
                    },
                    {
                        "drugbank-id": "DB00014",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Goserelin"
                    },
                    {
                        "drugbank-id": "DB00199",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB00207",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Azithromycin"
                    },
                    {
                        "drugbank-id": "DB00218",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Moxifloxacin"
                    },
                    {
                        "drugbank-id": "DB00243",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Ranolazine"
                    },
                    {
                        "drugbank-id": "DB00263",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Sulfisoxazole"
                    },
                    {
                        "drugbank-id": "DB00321",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Amitriptyline"
                    },
                    {
                        "drugbank-id": "DB00363",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Clozapine"
                    },
                    {
                        "drugbank-id": "DB00420",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Promazine"
                    },
                    {
                        "drugbank-id": "DB00433",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Prochlorperazine"
                    },
                    {
                        "drugbank-id": "DB00450",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Droperidol"
                    },
                    {
                        "drugbank-id": "DB00458",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Imipramine"
                    },
                    {
                        "drugbank-id": "DB00526",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Oxaliplatin"
                    },
                    {
                        "drugbank-id": "DB00537",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Ciprofloxacin"
                    },
                    {
                        "drugbank-id": "DB00544",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Fluorouracil"
                    },
                    {
                        "drugbank-id": "DB00556",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Perflutren"
                    },
                    {
                        "drugbank-id": "DB00608",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Chloroquine"
                    },
                    {
                        "drugbank-id": "DB00625",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Efavirenz"
                    },
                    {
                        "drugbank-id": "DB00738",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Pentamidine"
                    },
                    {
                        "drugbank-id": "DB00743",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Gadobenic acid"
                    },
                    {
                        "drugbank-id": "DB00748",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Carbinoxamine"
                    },
                    {
                        "drugbank-id": "DB00757",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Dolasetron"
                    },
                    {
                        "drugbank-id": "DB00778",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Roxithromycin"
                    },
                    {
                        "drugbank-id": "DB00779",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Nalidixic acid"
                    },
                    {
                        "drugbank-id": "DB00827",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Cinoxacin"
                    },
                    {
                        "drugbank-id": "DB00889",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Granisetron"
                    },
                    {
                        "drugbank-id": "DB00904",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00933",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00976",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Telithromycin"
                    },
                    {
                        "drugbank-id": "DB00978",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Lomefloxacin"
                    },
                    {
                        "drugbank-id": "DB00985",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Dimenhydrinate"
                    },
                    {
                        "drugbank-id": "DB01087",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Primaquine"
                    },
                    {
                        "drugbank-id": "DB01113",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Papaverine"
                    },
                    {
                        "drugbank-id": "DB01114",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Chlorpheniramine"
                    },
                    {
                        "drugbank-id": "DB01137",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Levofloxacin"
                    },
                    {
                        "drugbank-id": "DB01155",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Gemifloxacin"
                    },
                    {
                        "drugbank-id": "DB01165",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Ofloxacin"
                    },
                    {
                        "drugbank-id": "DB01211",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Clarithromycin"
                    },
                    {
                        "drugbank-id": "DB01232",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Saquinavir"
                    },
                    {
                        "drugbank-id": "DB01242",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Clomipramine"
                    },
                    {
                        "drugbank-id": "DB01599",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Probucol"
                    },
                    {
                        "drugbank-id": "DB01615",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Aceprometazine"
                    },
                    {
                        "drugbank-id": "DB02638",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Terlipressin"
                    },
                    {
                        "drugbank-id": "DB04948",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Lofexidine"
                    },
                    {
                        "drugbank-id": "DB05223",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Pracinostat"
                    },
                    {
                        "drugbank-id": "DB05488",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Technetium Tc 99m ciprofloxacin"
                    },
                    {
                        "drugbank-id": "DB06160",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Garenoxacin"
                    },
                    {
                        "drugbank-id": "DB06334",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Tucidinostat"
                    },
                    {
                        "drugbank-id": "DB06402",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Telavancin"
                    },
                    {
                        "drugbank-id": "DB06589",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Pazopanib"
                    },
                    {
                        "drugbank-id": "DB06600",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Nemonoxacin"
                    },
                    {
                        "drugbank-id": "DB06603",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Panobinostat"
                    },
                    {
                        "drugbank-id": "DB08799",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Antazoline"
                    },
                    {
                        "drugbank-id": "DB08865",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Crizotinib"
                    },
                    {
                        "drugbank-id": "DB08903",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Bedaquiline"
                    },
                    {
                        "drugbank-id": "DB09016",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Butriptyline"
                    },
                    {
                        "drugbank-id": "DB09063",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Ceritinib"
                    },
                    {
                        "drugbank-id": "DB09078",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Lenvatinib"
                    },
                    {
                        "drugbank-id": "DB09555",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB11640",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB11830",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Mocetinostat"
                    },
                    {
                        "drugbank-id": "DB11841",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Entinostat"
                    },
                    {
                        "drugbank-id": "DB12141",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Gilteritinib"
                    },
                    {
                        "drugbank-id": "DB12174",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with CUDC 101"
                    },
                    {
                        "drugbank-id": "DB12376",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Ricolinostat"
                    },
                    {
                        "drugbank-id": "DB12523",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Mizolastine"
                    },
                    {
                        "drugbank-id": "DB12565",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Abexinostat"
                    },
                    {
                        "drugbank-id": "DB12877",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Oxatomide"
                    },
                    {
                        "drugbank-id": "DB13261",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Sitafloxacin"
                    },
                    {
                        "drugbank-id": "DB13273",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Sultopride"
                    },
                    {
                        "drugbank-id": "DB13679",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Dexchlorpheniramine"
                    },
                    {
                        "drugbank-id": "DB14568",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Ivosidenib"
                    },
                    {
                        "drugbank-id": "DB01224",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Quetiapine"
                    },
                    {
                        "drugbank-id": "DB11718",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Encorafenib"
                    },
                    {
                        "drugbank-id": "DB01084",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Emedastine"
                    },
                    {
                        "drugbank-id": "DB15982",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Berotralstat"
                    },
                    {
                        "drugbank-id": "DB00215",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Citalopram"
                    },
                    {
                        "drugbank-id": "DB00261",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00283",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Clemastine"
                    },
                    {
                        "drugbank-id": "DB00313",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Valproic acid"
                    },
                    {
                        "drugbank-id": "DB00342",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Terfenadine"
                    },
                    {
                        "drugbank-id": "DB00365",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Grepafloxacin"
                    },
                    {
                        "drugbank-id": "DB00468",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Quinine"
                    },
                    {
                        "drugbank-id": "DB00530",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Erlotinib"
                    },
                    {
                        "drugbank-id": "DB00539",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Toremifene"
                    },
                    {
                        "drugbank-id": "DB00604",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Cisapride"
                    },
                    {
                        "drugbank-id": "DB00619",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Imatinib"
                    },
                    {
                        "drugbank-id": "DB00637",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Astemizole"
                    },
                    {
                        "drugbank-id": "DB00679",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Thioridazine"
                    },
                    {
                        "drugbank-id": "DB00685",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Trovafloxacin"
                    },
                    {
                        "drugbank-id": "DB00834",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Mifepristone"
                    },
                    {
                        "drugbank-id": "DB00875",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Flupentixol"
                    },
                    {
                        "drugbank-id": "DB00907",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Cocaine"
                    },
                    {
                        "drugbank-id": "DB01100",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Pimozide"
                    },
                    {
                        "drugbank-id": "DB01169",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Arsenic trioxide"
                    },
                    {
                        "drugbank-id": "DB01175",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Escitalopram"
                    },
                    {
                        "drugbank-id": "DB01208",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Sparfloxacin"
                    },
                    {
                        "drugbank-id": "DB01218",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB01267",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Paliperidone"
                    },
                    {
                        "drugbank-id": "DB01356",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB01405",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Temafloxacin"
                    },
                    {
                        "drugbank-id": "DB01624",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Zuclopenthixol"
                    },
                    {
                        "drugbank-id": "DB04844",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Tetrabenazine"
                    },
                    {
                        "drugbank-id": "DB04868",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Nilotinib"
                    },
                    {
                        "drugbank-id": "DB04946",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Iloperidone"
                    },
                    {
                        "drugbank-id": "DB05294",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Vandetanib"
                    },
                    {
                        "drugbank-id": "DB06176",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Romidepsin"
                    },
                    {
                        "drugbank-id": "DB06216",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Asenapine"
                    },
                    {
                        "drugbank-id": "DB06697",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Artemether"
                    },
                    {
                        "drugbank-id": "DB06708",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Lumefantrine"
                    },
                    {
                        "drugbank-id": "DB09039",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Eliglustat"
                    },
                    {
                        "drugbank-id": "DB09083",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Ivabradine"
                    },
                    {
                        "drugbank-id": "DB11730",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Ribociclib"
                    },
                    {
                        "drugbank-id": "DB11978",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB12161",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Deutetrabenazine"
                    },
                    {
                        "drugbank-id": "DB08881",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Vemurafenib"
                    },
                    {
                        "drugbank-id": "DB11637",
                        "description": "Hyoscyamine may increase the QTc prolonging activities of Delamanid"
                    },
                    {
                        "drugbank-id": "DB09532",
                        "description": "The therapeutic efficacy of Secretin human can be decreased when used in combination with Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00245",
                        "description": "The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00354",
                        "description": "The risk or severity of QTc prolongation can be increased when Buclizine is combined with Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB01036",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Tolterodine"
                    },
                    {
                        "drugbank-id": "DB01591",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Solifenacin"
                    },
                    {
                        "drugbank-id": "DB00999",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Hydrochlorothiazide"
                    },
                    {
                        "drugbank-id": "DB00358",
                        "description": "The risk or severity of QTc prolongation can be increased when Mefloquine is combined with Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00674",
                        "description": "The risk or severity of QTc prolongation can be increased when Galantamine is combined with Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00871",
                        "description": "The risk or severity of QTc prolongation can be increased when Terbutaline is combined with Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB11390",
                        "description": "The risk or severity of QTc prolongation can be increased when Coumaphos is combined with Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB11397",
                        "description": "The risk or severity of QTc prolongation can be increased when Dichlorvos is combined with Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB11412",
                        "description": "The risk or severity of QTc prolongation can be increased when Fenthion is combined with Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00104",
                        "description": "The risk or severity of QTc prolongation can be increased when Octreotide is combined with Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00107",
                        "description": "The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00188",
                        "description": "The risk or severity of QTc prolongation can be increased when Bortezomib is combined with Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00196",
                        "description": "The risk or severity of QTc prolongation can be increased when Fluconazole is combined with Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00220",
                        "description": "The risk or severity of QTc prolongation can be increased when Nelfinavir is combined with Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00346",
                        "description": "The risk or severity of QTc prolongation can be increased when Alfuzosin is combined with Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00374",
                        "description": "The risk or severity of QTc prolongation can be increased when Treprostinil is combined with Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00398",
                        "description": "The risk or severity of QTc prolongation can be increased when Sorafenib is combined with Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00467",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Enoxacin"
                    },
                    {
                        "drugbank-id": "DB00487",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Pefloxacin"
                    },
                    {
                        "drugbank-id": "DB00503",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Ritonavir"
                    },
                    {
                        "drugbank-id": "DB00529",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Foscarnet"
                    },
                    {
                        "drugbank-id": "DB00582",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Voriconazole"
                    },
                    {
                        "drugbank-id": "DB00613",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Amodiaquine"
                    },
                    {
                        "drugbank-id": "DB00675",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Tamoxifen"
                    },
                    {
                        "drugbank-id": "DB00691",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Moexipril"
                    },
                    {
                        "drugbank-id": "DB00710",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Ibandronate"
                    },
                    {
                        "drugbank-id": "DB00719",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Azatadine"
                    },
                    {
                        "drugbank-id": "DB00808",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Indapamide"
                    },
                    {
                        "drugbank-id": "DB00817",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Rosoxacin"
                    },
                    {
                        "drugbank-id": "DB00822",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Disulfiram"
                    },
                    {
                        "drugbank-id": "DB00862",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Vardenafil"
                    },
                    {
                        "drugbank-id": "DB00864",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Tacrolimus"
                    },
                    {
                        "drugbank-id": "DB00915",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Amantadine"
                    },
                    {
                        "drugbank-id": "DB00916",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Metronidazole"
                    },
                    {
                        "drugbank-id": "DB00920",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Ketotifen"
                    },
                    {
                        "drugbank-id": "DB00927",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Famotidine"
                    },
                    {
                        "drugbank-id": "DB00938",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Salmeterol"
                    },
                    {
                        "drugbank-id": "DB00983",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Formoterol"
                    },
                    {
                        "drugbank-id": "DB01001",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Salbutamol"
                    },
                    {
                        "drugbank-id": "DB01015",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Sulfamethoxazole"
                    },
                    {
                        "drugbank-id": "DB01026",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Ketoconazole"
                    },
                    {
                        "drugbank-id": "DB01044",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Gatifloxacin"
                    },
                    {
                        "drugbank-id": "DB01059",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Norfloxacin"
                    },
                    {
                        "drugbank-id": "DB01071",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Mequitazine"
                    },
                    {
                        "drugbank-id": "DB01072",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Atazanavir"
                    },
                    {
                        "drugbank-id": "DB01166",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Cilostazol"
                    },
                    {
                        "drugbank-id": "DB01167",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Itraconazole"
                    },
                    {
                        "drugbank-id": "DB01254",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Dasatinib"
                    },
                    {
                        "drugbank-id": "DB01259",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB01263",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB01268",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Sunitinib"
                    },
                    {
                        "drugbank-id": "DB01274",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Arformoterol"
                    },
                    {
                        "drugbank-id": "DB01611",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Hydroxychloroquine"
                    },
                    {
                        "drugbank-id": "DB01620",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Pheniramine"
                    },
                    {
                        "drugbank-id": "DB02546",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Vorinostat"
                    },
                    {
                        "drugbank-id": "DB04576",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Fleroxacin"
                    },
                    {
                        "drugbank-id": "DB04695",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Farnesyl thiopyrophosphate"
                    },
                    {
                        "drugbank-id": "DB05039",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB05465",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Tandutinib"
                    },
                    {
                        "drugbank-id": "DB06663",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Pasireotide"
                    },
                    {
                        "drugbank-id": "DB06699",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Degarelix"
                    },
                    {
                        "drugbank-id": "DB06719",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Buserelin"
                    },
                    {
                        "drugbank-id": "DB06788",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Histrelin"
                    },
                    {
                        "drugbank-id": "DB06825",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Triptorelin"
                    },
                    {
                        "drugbank-id": "DB07780",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Farnesyl diphosphate"
                    },
                    {
                        "drugbank-id": "DB07841",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Geranylgeranyl diphosphate"
                    },
                    {
                        "drugbank-id": "DB08864",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Rilpivirine"
                    },
                    {
                        "drugbank-id": "DB08871",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Eribulin"
                    },
                    {
                        "drugbank-id": "DB08912",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Dabrafenib"
                    },
                    {
                        "drugbank-id": "DB08936",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Chlorcyclizine"
                    },
                    {
                        "drugbank-id": "DB08972",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Flumequine"
                    },
                    {
                        "drugbank-id": "DB09080",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Olodaterol"
                    },
                    {
                        "drugbank-id": "DB09082",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB09488",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Acrivastine"
                    },
                    {
                        "drugbank-id": "DB11408",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Famphur"
                    },
                    {
                        "drugbank-id": "DB11443",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Orbifloxacin"
                    },
                    {
                        "drugbank-id": "DB11448",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Phosmet"
                    },
                    {
                        "drugbank-id": "DB11491",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Sarafloxacin"
                    },
                    {
                        "drugbank-id": "DB11511",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Difloxacin"
                    },
                    {
                        "drugbank-id": "DB11591",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Bilastine"
                    },
                    {
                        "drugbank-id": "DB11614",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Rupatadine"
                    },
                    {
                        "drugbank-id": "DB11742",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Ebastine"
                    },
                    {
                        "drugbank-id": "DB11774",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Pazufloxacin"
                    },
                    {
                        "drugbank-id": "DB11891",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with CUDC 907"
                    },
                    {
                        "drugbank-id": "DB11892",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Prulifloxacin"
                    },
                    {
                        "drugbank-id": "DB11943",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Delafloxacin"
                    },
                    {
                        "drugbank-id": "DB12231",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Temefos"
                    },
                    {
                        "drugbank-id": "DB12245",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Triclabendazole"
                    },
                    {
                        "drugbank-id": "DB12645",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Givinostat"
                    },
                    {
                        "drugbank-id": "DB13627",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Oxolinic acid"
                    },
                    {
                        "drugbank-id": "DB13744",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Piromidic acid"
                    },
                    {
                        "drugbank-id": "DB13772",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Rufloxacin"
                    },
                    {
                        "drugbank-id": "DB13823",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Pipemidic acid"
                    },
                    {
                        "drugbank-id": "DB14713",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Inotersen"
                    },
                    {
                        "drugbank-id": "DB01601",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Lopinavir"
                    },
                    {
                        "drugbank-id": "DB00845",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Clofazimine"
                    },
                    {
                        "drugbank-id": "DB11796",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB11853",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Relugolix"
                    },
                    {
                        "drugbank-id": "DB01235",
                        "description": "The absorption of Levodopa can be decreased when combined with Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00455",
                        "description": "Hyoscyamine may increase the anticholinergic activities of Loratadine"
                    },
                    {
                        "drugbank-id": "DB00184",
                        "description": "The risk or severity of Tachycardia can be increased when Nicotine is combined with Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00191",
                        "description": "The risk or severity of Tachycardia can be increased when Phentermine is combined with Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00211",
                        "description": "The risk or severity of Tachycardia can be increased when Midodrine is combined with Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00217",
                        "description": "The risk or severity of Tachycardia can be increased when Bethanidine is combined with Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00221",
                        "description": "The risk or severity of Tachycardia can be increased when Isoetharine is combined with Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00368",
                        "description": "The risk or severity of Tachycardia can be increased when Norepinephrine is combined with Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00388",
                        "description": "The risk or severity of Tachycardia can be increased when Phenylephrine is combined with Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00397",
                        "description": "The risk or severity of Tachycardia can be increased when Phenylpropanolamine is combined with Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00598",
                        "description": "The risk or severity of Tachycardia can be increased when Hyoscyamine is combined with Labetalol"
                    },
                    {
                        "drugbank-id": "DB00610",
                        "description": "The risk or severity of Tachycardia can be increased when Hyoscyamine is combined with Metaraminol"
                    },
                    {
                        "drugbank-id": "DB00629",
                        "description": "The risk or severity of Tachycardia can be increased when Hyoscyamine is combined with Guanabenz"
                    },
                    {
                        "drugbank-id": "DB00668",
                        "description": "The risk or severity of Tachycardia can be increased when Hyoscyamine is combined with Epinephrine"
                    },
                    {
                        "drugbank-id": "DB00723",
                        "description": "The risk or severity of Tachycardia can be increased when Hyoscyamine is combined with Methoxamine"
                    },
                    {
                        "drugbank-id": "DB00810",
                        "description": "The risk or severity of Tachycardia can be increased when Hyoscyamine is combined with Biperiden"
                    },
                    {
                        "drugbank-id": "DB00816",
                        "description": "The risk or severity of Tachycardia can be increased when Hyoscyamine is combined with Orciprenaline"
                    },
                    {
                        "drugbank-id": "DB00830",
                        "description": "The risk or severity of Tachycardia can be increased when Hyoscyamine is combined with Phenmetrazine"
                    },
                    {
                        "drugbank-id": "DB00841",
                        "description": "The risk or severity of Tachycardia can be increased when Hyoscyamine is combined with Dobutamine"
                    },
                    {
                        "drugbank-id": "DB00852",
                        "description": "The risk or severity of Tachycardia can be increased when Hyoscyamine is combined with Pseudoephedrine"
                    },
                    {
                        "drugbank-id": "DB00867",
                        "description": "The risk or severity of Tachycardia can be increased when Hyoscyamine is combined with Ritodrine"
                    },
                    {
                        "drugbank-id": "DB00901",
                        "description": "The risk or severity of Tachycardia can be increased when Hyoscyamine is combined with Bitolterol"
                    },
                    {
                        "drugbank-id": "DB00935",
                        "description": "The risk or severity of Tachycardia can be increased when Hyoscyamine is combined with Oxymetazoline"
                    },
                    {
                        "drugbank-id": "DB00988",
                        "description": "The risk or severity of Tachycardia can be increased when Hyoscyamine is combined with Dopamine"
                    },
                    {
                        "drugbank-id": "DB01064",
                        "description": "The risk or severity of Tachycardia can be increased when Hyoscyamine is combined with Isoprenaline"
                    },
                    {
                        "drugbank-id": "DB01102",
                        "description": "The risk or severity of Tachycardia can be increased when Hyoscyamine is combined with Arbutamine"
                    },
                    {
                        "drugbank-id": "DB01255",
                        "description": "The risk or severity of Tachycardia can be increased when Hyoscyamine is combined with Lisdexamfetamine"
                    },
                    {
                        "drugbank-id": "DB01291",
                        "description": "The risk or severity of Tachycardia can be increased when Hyoscyamine is combined with Pirbuterol"
                    },
                    {
                        "drugbank-id": "DB01363",
                        "description": "The risk or severity of Tachycardia can be increased when Hyoscyamine is combined with Ephedra sinica root"
                    },
                    {
                        "drugbank-id": "DB01364",
                        "description": "The risk or severity of Tachycardia can be increased when Hyoscyamine is combined with Ephedrine"
                    },
                    {
                        "drugbank-id": "DB01365",
                        "description": "The risk or severity of Tachycardia can be increased when Hyoscyamine is combined with Mephentermine"
                    },
                    {
                        "drugbank-id": "DB01366",
                        "description": "The risk or severity of Tachycardia can be increased when Hyoscyamine is combined with Procaterol"
                    },
                    {
                        "drugbank-id": "DB01407",
                        "description": "The risk or severity of Tachycardia can be increased when Hyoscyamine is combined with Clenbuterol"
                    },
                    {
                        "drugbank-id": "DB01467",
                        "description": "The risk or severity of Tachycardia can be increased when Hyoscyamine is combined with 2 5 Dimethoxy 4 ethylamphetamine"
                    },
                    {
                        "drugbank-id": "DB01556",
                        "description": "The risk or severity of Tachycardia can be increased when Hyoscyamine is combined with Chlorphentermine"
                    },
                    {
                        "drugbank-id": "DB01576",
                        "description": "The risk or severity of Tachycardia can be increased when Hyoscyamine is combined with Dextroamphetamine"
                    },
                    {
                        "drugbank-id": "DB01579",
                        "description": "The risk or severity of Tachycardia can be increased when Hyoscyamine is combined with Phendimetrazine"
                    },
                    {
                        "drugbank-id": "DB05395",
                        "description": "The risk or severity of Tachycardia can be increased when Hyoscyamine is combined with Amibegron"
                    },
                    {
                        "drugbank-id": "DB06190",
                        "description": "The risk or severity of Tachycardia can be increased when Hyoscyamine is combined with Solabegron"
                    },
                    {
                        "drugbank-id": "DB06262",
                        "description": "The risk or severity of Tachycardia can be increased when Hyoscyamine is combined with Droxidopa"
                    },
                    {
                        "drugbank-id": "DB06706",
                        "description": "The risk or severity of Tachycardia can be increased when Hyoscyamine is combined with Isometheptene"
                    },
                    {
                        "drugbank-id": "DB06707",
                        "description": "The risk or severity of Tachycardia can be increased when Hyoscyamine is combined with Levonordefrin"
                    },
                    {
                        "drugbank-id": "DB06711",
                        "description": "The risk or severity of Tachycardia can be increased when Hyoscyamine is combined with Naphazoline"
                    },
                    {
                        "drugbank-id": "DB06764",
                        "description": "The risk or severity of Tachycardia can be increased when Hyoscyamine is combined with Tetryzoline"
                    },
                    {
                        "drugbank-id": "DB06814",
                        "description": "The risk or severity of Tachycardia can be increased when Hyoscyamine is combined with Protokylol"
                    },
                    {
                        "drugbank-id": "DB08841",
                        "description": "The risk or severity of Tachycardia can be increased when Hyoscyamine is combined with Tyramine"
                    },
                    {
                        "drugbank-id": "DB08925",
                        "description": "The risk or severity of Tachycardia can be increased when Hyoscyamine is combined with Adrafinil"
                    },
                    {
                        "drugbank-id": "DB08941",
                        "description": "The risk or severity of Tachycardia can be increased when Hyoscyamine is combined with Isoxsuprine"
                    },
                    {
                        "drugbank-id": "DB08957",
                        "description": "The risk or severity of Tachycardia can be increased when Hyoscyamine is combined with Hexoprenaline"
                    },
                    {
                        "drugbank-id": "DB08985",
                        "description": "The risk or severity of Tachycardia can be increased when Hyoscyamine is combined with Etilefrine"
                    },
                    {
                        "drugbank-id": "DB09202",
                        "description": "The risk or severity of Tachycardia can be increased when Hyoscyamine is combined with Cirazoline"
                    },
                    {
                        "drugbank-id": "DB09203",
                        "description": "The risk or severity of Tachycardia can be increased when Hyoscyamine is combined with Synephrine"
                    },
                    {
                        "drugbank-id": "DB09242",
                        "description": "The risk or severity of Tachycardia can be increased when Hyoscyamine is combined with Moxonidine"
                    },
                    {
                        "drugbank-id": "DB09273",
                        "description": "The risk or severity of Tachycardia can be increased when Hyoscyamine is combined with Doxofylline"
                    },
                    {
                        "drugbank-id": "DB09480",
                        "description": "The risk or severity of Tachycardia can be increased when Hyoscyamine is combined with Iofetamine I 123"
                    },
                    {
                        "drugbank-id": "DB11124",
                        "description": "The risk or severity of Tachycardia can be increased when Hyoscyamine is combined with Racepinephrine"
                    },
                    {
                        "drugbank-id": "DB11278",
                        "description": "The risk or severity of Tachycardia can be increased when Hyoscyamine is combined with DL Methylephedrine"
                    },
                    {
                        "drugbank-id": "DB11373",
                        "description": "The risk or severity of Tachycardia can be increased when Hyoscyamine is combined with Amitraz"
                    },
                    {
                        "drugbank-id": "DB11541",
                        "description": "The risk or severity of Tachycardia can be increased when Hyoscyamine is combined with Ractopamine"
                    },
                    {
                        "drugbank-id": "DB11587",
                        "description": "The risk or severity of Tachycardia can be increased when Hyoscyamine is combined with Etafedrine"
                    },
                    {
                        "drugbank-id": "DB11738",
                        "description": "The risk or severity of Tachycardia can be increased when Hyoscyamine is combined with Rilmenidine"
                    },
                    {
                        "drugbank-id": "DB11871",
                        "description": "The risk or severity of Tachycardia can be increased when Hyoscyamine is combined with PF 00610355"
                    },
                    {
                        "drugbank-id": "DB12080",
                        "description": "The risk or severity of Tachycardia can be increased when Hyoscyamine is combined with Ritobegron"
                    },
                    {
                        "drugbank-id": "DB12100",
                        "description": "The risk or severity of Tachycardia can be increased when Hyoscyamine is combined with Abediterol"
                    },
                    {
                        "drugbank-id": "DB12248",
                        "description": "The risk or severity of Tachycardia can be increased when Hyoscyamine is combined with Tulobuterol"
                    },
                    {
                        "drugbank-id": "DB12313",
                        "description": "The risk or severity of Tachycardia can be increased when Hyoscyamine is combined with Dopexamine"
                    },
                    {
                        "drugbank-id": "DB12779",
                        "description": "The risk or severity of Tachycardia can be increased when Hyoscyamine is combined with Higenamine"
                    },
                    {
                        "drugbank-id": "DB12846",
                        "description": "The risk or severity of Tachycardia can be increased when Hyoscyamine is combined with Reproterol"
                    },
                    {
                        "drugbank-id": "DB13064",
                        "description": "The risk or severity of Tachycardia can be increased when Hyoscyamine is combined with Tramazoline"
                    },
                    {
                        "drugbank-id": "DB13108",
                        "description": "The risk or severity of Tachycardia can be increased when Hyoscyamine is combined with Mephedrone"
                    },
                    {
                        "drugbank-id": "DB13139",
                        "description": "The risk or severity of Tachycardia can be increased when Hyoscyamine is combined with Levosalbutamol"
                    },
                    {
                        "drugbank-id": "DB13251",
                        "description": "The risk or severity of Tachycardia can be increased when Hyoscyamine is combined with Octopamine"
                    },
                    {
                        "drugbank-id": "DB13341",
                        "description": "The risk or severity of Tachycardia can be increased when Hyoscyamine is combined with Fenozolone"
                    },
                    {
                        "drugbank-id": "DB13378",
                        "description": "The risk or severity of Tachycardia can be increased when Hyoscyamine is combined with Norfenefrine"
                    },
                    {
                        "drugbank-id": "DB13398",
                        "description": "The risk or severity of Tachycardia can be increased when Hyoscyamine is combined with Oxyfedrine"
                    },
                    {
                        "drugbank-id": "DB13559",
                        "description": "The risk or severity of Tachycardia can be increased when Hyoscyamine is combined with Rimiterol"
                    },
                    {
                        "drugbank-id": "DB13624",
                        "description": "The risk or severity of Tachycardia can be increased when Hyoscyamine is combined with Methoxyphenamine"
                    },
                    {
                        "drugbank-id": "DB13692",
                        "description": "The risk or severity of Tachycardia can be increased when Hyoscyamine is combined with Tretoquinol"
                    },
                    {
                        "drugbank-id": "DB13703",
                        "description": "The risk or severity of Tachycardia can be increased when Hyoscyamine is combined with Gepefrine"
                    },
                    {
                        "drugbank-id": "DB13777",
                        "description": "The risk or severity of Tachycardia can be increased when Hyoscyamine is combined with Prenalterol"
                    },
                    {
                        "drugbank-id": "DB13781",
                        "description": "The risk or severity of Tachycardia can be increased when Hyoscyamine is combined with Xamoterol"
                    },
                    {
                        "drugbank-id": "DB13852",
                        "description": "The risk or severity of Tachycardia can be increased when Hyoscyamine is combined with Mefenorex"
                    },
                    {
                        "drugbank-id": "DB14009",
                        "description": "The risk or severity of Tachycardia can be increased when Hyoscyamine is combined with Medical Cannabis"
                    },
                    {
                        "drugbank-id": "DB01184",
                        "description": "The therapeutic efficacy of Domperidone can be decreased when used in combination with Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB13074",
                        "description": "The therapeutic efficacy of Macimorelin can be decreased when used in combination with Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB14754",
                        "description": "The risk or severity of Tachycardia can be increased when Solriamfetol is combined with Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00612",
                        "description": "The therapeutic efficacy of Hyoscyamine can be increased when used in combination with Bisoprolol"
                    },
                    {
                        "drugbank-id": "DB00656",
                        "description": "The risk or severity of QTc prolongation can be increased when Trazodone is combined with Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00843",
                        "description": "The therapeutic efficacy of Hyoscyamine can be decreased when used in combination with Donepezil"
                    },
                    {
                        "drugbank-id": "DB11986",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Entrectinib"
                    },
                    {
                        "drugbank-id": "DB11642",
                        "description": "Hyoscyamine may increase the QTc prolonging activities of Pitolisant"
                    },
                    {
                        "drugbank-id": "DB12825",
                        "description": "Lefamulin may increase the QTc prolonging activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB01233",
                        "description": "The therapeutic efficacy of Hyoscyamine can be decreased when used in combination with Metoclopramide"
                    },
                    {
                        "drugbank-id": "DB00557",
                        "description": "The risk or severity of QTc prolongation can be increased when Hydroxyzine is combined with Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB01118",
                        "description": "The risk or severity of adverse effects can be increased when Hyoscyamine is combined with Amiodarone"
                    },
                    {
                        "drugbank-id": "DB00246",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Ziprasidone"
                    },
                    {
                        "drugbank-id": "DB00502",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Haloperidol"
                    },
                    {
                        "drugbank-id": "DB00472",
                        "description": "The risk or severity of QTc prolongation can be increased when Fluoxetine is combined with Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB14881",
                        "description": "The risk or severity of urinary retention reduced gastrointestinal motility and constipation can be increased when Hyoscyamine is combined with Oliceridine"
                    }
                ]
            }
        },
        "revision_date": "2023-05-14"
    }
}